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Abstract
Objective. To estimate risk of dementia in association with exposure to air pollutants.
Methods. Six databases were searched. Cohort studies that reported the hazard ratio (HR) of
dementia in association with exposure to air pollutants in adults > 40y were included. For all
meta-analyses, the random-effects model was used.
Results. A total of 16 and 13 studies were included in the systematic review and the metaanalysis, respectively. Risk of dementia increased by 4% per 1μg/m3 increase in fine particulate
matter level (HR, 1.04; 95%CI, [1.02, 1.06]), which was statistically significant. The risk of
dementia increased by 3% per 10μg/m3 increase in nitrogen oxides level (HR, 1.03; 95%CI,
[0.98, 1.08]), and by 3% per 10μg/m3 increase in nitrogen dioxide level (HR, 1.03; 95%CI,
[1.00, 1.07]); however, the associations were not statistically significant
Conclusion. This meta-analysis indicates a significant association between exposure to fine
particulate matter and incidence of dementia.
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Summary for Lay Audience
Objective. To estimate risk of dementia in association with exposure to air pollutants.
Methods. Six databases were searched for long-term studies. Those reported the risk of
dementia in association to exposure to air pollutants in adults who were older than 40 years of
age were included, and analyses of similar studies were conducted
Results. A total of 13 studies were included in the analyses of similar studies. The risk of
dementia increased by 4% per 1μg/m3 increase in fine particles level, which was statistically
significant. The risk of dementia increased by 3% per 10μg/m3 increase in nitrogen oxides
level, and by 3% per 10μg/m3 increase in nitrogen dioxide level; however, the associations
were not statistically significant
Conclusion. This analysis of similar studies indicates a significant association between
exposure to fine particulate matter and incidence of dementia.
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Chapter 1

1

Introduction

1.1 Dementia
Neurological disorders account for 10% of the global burden of disease and are the leading
cause of disability-adjusted life years (DALYs). About 10% of DALYs from neurological
disorders are due to dementia. While the trend of prevalence and incidence of dementia is
stable or declining in high-income countries, low-income and middle-income countries are
expecting a rise in the burden of dementia (1). The annual cost of dementia in the United
States was estimated to be around 157 to 215 billion dollars (2). While the Canadian
population is considerably smaller than the United States, the burden of dementia was
reported to be 15 billion dollars in 2008, and is expected to reach 153 billion dollars in
2038 (3, 4).
Dementia is categorized as Alzheimer’s disease (AD) and non-Alzheimer dementia (NAD)
with AD being the most commonly diagnosed type of dementia. An important proportion
of NAD is vascular dementia (VaD). The subtypes of dementia including AD are diagnosed
clinically; however, neuropathological examination of the brain of 1,161 deceased
individuals with dementia demonstrated that 41% of AD cases could be attributed to AD
pathology alone and pathological features related to other types of dementia could be seen
in those diagnosed with dementia. In addition, over two-thirds of cases of AD could be
attributed to other neuropathologies that were common for the age of individuals (5). These
findings infer that relying on the clinical diagnosis of dementia subtypes might be
misleading, and it is better to evaluate all of them under the umbrella of dementia.
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Numerous genetic, behavioural, and environmental factors are associated with dementia.
The important risk factors for dementia are age, female sex, traumatic brain injury, current
smoking, low educational level, and pre-existing metabolic disorders or cardiovascular
diseases (CVD) (6, 7). Age is the most important risk factor for developing dementia and
the prevalence increases from 2% to 3% at age 65 to more than 30% at age 90 or older (810). Along with the increasing population worldwide and improvement in public health,
the elderly will constitute a large proportion of the population. It means that an increase in
chronic and non-communicable diseases of the elderly, including dementia, should be
expected. It is estimated that the number of people with dementia will rise from 44 million
individuals in 2013 to 135 million in 2050 (11). Due to such an important effect on health
and economy, the World Health Organization announced dementia as a public health
priority (12). Therefore, understanding and preventing the causes of dementia would be
beneficial to both healthcare systems and governments.
One of the environmental factors that is hypothesized to be associated with dementia is air
pollution. Air pollution has become a global concern during the recent decades and its
association with numerous medical conditions has been reported. During the last decade,
the association of air pollutants with cognitive decline and dementia has been examined
and there was a discrepancy among the reported associations.

1.2

Air pollution

Air pollution has been associated with adverse health outcomes (13). There is a large body
of evidence that associates air pollution to CVD (14), respiratory diseases (15-17),
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psychiatric disorders such as depression and suicide (17), and neurological disorders
including decline in cognitive function and dementia (18, 19).
The pollutants can be of natural sources or human-activity-related sources. Natural sources
include volcanic activities, wildfire, and dust, and are difficult to control. Sources related
to human-activity are mainly from traffic, home cooking and heating, industrial
combustion of fossil fuels, mining, and agriculture. Human-activity-related pollutants can
be reduced with appropriate intervention. Some of the most important air pollutants are
particulate matter (PM), especially PM of diameter less than 2.5μm (PM2.5), nitrogen
oxides (NOX) including nitrogen dioxide (NO2) and nitrogen monoxide (NO), and ozone
(O3). Some strategies to decrease traffic-related air pollution have shown beneficial effects
on health (20). Therefore, the level of air pollutants should be kept low to prevent
detrimental health outcomes. The World Health Organization (WHO) air quality guideline
indicated that the annual and daily mean levels of PM2.5 should not exceed 10μg/m3 and
25μg/m3, respectively. The guideline levels for the annual and daily mean levels of NO2
are 40μg/m3 and 200μg/m3, respectively. The recommended threshold for mean levels of
O3 is 100μg/m3/8 hour. Nonetheless, according to “Ambient (outdoor) air quality and
health” report by WHO in 2016, about 91% of the world population were living in regions
where the level of pollutants exceeded the WHO air quality guidelines. This report also
estimated that about 4.2 million premature deaths worldwide were due to exposure to air
pollution. Most of the deaths occurred in low-income and middle-income countries (21).

4

1.2.1

Particulate Matter

Particulate matter (PM) is a collective name for a group of particles with different sizes
and various composition that can be liquid or solid. Particulate matter might be of natural
or human-activity-related sources. The primary PM is produced directly from natural or
human-activity-related sources. Secondary PM is a complex combination of different
pollutants due to photochemical reactions in the atmosphere (22).
Particulate matter is produced in various sizes. The United States Environmental Protection
Agency (EPA) has categorized PM according to the diameter of the particles, ranging from
ultrafine, fine, and coarse PM.
Ultrafine PM has a dimeter of < 100nm and therefore, it is called PM0.1. The main
constituents of ultrafine PM are organic matters with inorganic ions and metals being its
minor constituents. The fine PM (PM2.5) has a diameter of < 2.5μm and its main
constituents are inorganic ions, with metals and organic matter being its minor constituents.
Coarse PM (PM10) has a diameter between 2.5μm and 10μm with inorganic ions and metals
being its main constituents (23). The importance of this categorization is that each particle
might have a different fate and unique effect on the human body.
While PM10 is mainly trapped in the upper respiratory tract, PM0.1 and PM2.5 not only
deposits in the lungs, but also enters the circulation and is taken up into cells and may cross
the brain-blood barrier (24). In addition, PM0.1 can directly enter the brain through olfactory
nerve endings in the nose (25). The surface of PM0.1 and PM2.5 can also carry other
hazardous chemicals and metals (26), and their entrance into the blood stream and brain
may lead to cell damage. The entrance of PM in the brain cells can initiate inflammation,
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neurotoxicity, neuronal damage, and cell loss (27). In addition, there is an association
between exposure to PM and cardiovascular morbidity and mortality (28), which is a risk
factor for dementia and can lead to cognitive impairment and contribute to the development
of dementia and AD (29).
While the negative effect of pollution on cognition has been studied in children whose
mothers were exposed to air pollution during pregnancy, the results have been discrepant.
One component of PM is the polycyclic aromatic hydrocarbons (PAHs) that is shown to
be associated with decreased verbal and overall IQ in 5-year-old children born to AfricanAmerican and Dominican mothers in New York city who were exposed to PAHs during
pregnancy (30). On the other hand, a meta-analysis of six European studies on the
association between prenatal exposure to air pollutants and psychomotor development did
not show any association with PM10 or PM2.5 (31). Harris et al. studied the association of
prenatal exposure to traffic-related air pollution, specifically PM2.5, in 1109 mother-child
pairs in Eastern Massachusetts and reported a limited association between exposure to
PM2.5 and childhood cognitive decline (32). This heterogeneity in suggested associations
might be due to different levels of exposure to pollutants and potential unknown
interactions between other pollutants affecting overall toxicity. In addition, PM is a mixture
of various chemical elements and its composition might differ from region to region and
from time to time according to other environmental factors.
The negative effect of exposure to air pollution is not limited to the prenatal period.
Childhood exposure to air pollutants is also associated with cognitive decline. In a pilot
study in Mexico City, Calderón-Garcidueñas et al. evaluated 134 consecutive autopsies of
subjects with the mean age of 20 (range, 11mo to 30y) and reported progressive
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development of AD in 99.25% of the autopsies. They also reported cognitive impairment
in 66% of healthy individuals ≤ 30 years old who were exposed to more than standard
levels of PM2.5 and O3 during their lifetime (33).
Numerous studies have shown the association between air pollution and cognitive decline
in the elderly population. In a study of elderly women from the SALIA cohort (duration,
22 y) in Germany, Schikawski et al. reported a significant decrease in the semantic memory
and visuo-construction subsets of cognitive function with increases in NOx and PM. In
addition, they reported a significant association of decline in cognitive function in the
carriers of APOE ϵ4 allele (34). Gatto et al. investigated the association of air pollution
with different domains of cognition in adults (mean age, 60.5 y) in Los Angeles and
reported lower verbal learning in those exposed to PM2.5 and lower logical memory in those
exposed to NO2 (35).
Alishire and Clarke studied the cognitive function of 780 Hispanic participants in the
American Changing Lives Study and evaluated the association of the cognitive errors with
exposure to PM2.5 using the Short Portable Mental Status Questionnaire (SPMSQ). Their
results showed that in comparison to exposure to the lower levels of PM2.5, exposure to
higher levels of PM2.5 was associated with 1.5 times higher error rates in working memory
and orientation domains of cognitive function (36).
Another study of 19,409 women from Nurses’ Health Study Cognitive Cohort in the United
States evaluated the association of PM with global cognition. This study indicated a decline
in global cognition among those who were exposed to higher levels of PM2.5 in comparison
to those exposed to lower levels. In addition, there was a linear association between
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increase in PM2.5 levels and decline in global cognition in a two-year evaluation interval.
They indicated that higher levels of PM was associated with faster cognition decline (37).
Lin et al. studied the association of PM2.5 with overall and domain-specific disability
according to the 12-item version of the World Health Organization Disability Assessment
Schedule (WHODAS 2.0) among adults of six low-income and middle-income countries.
Evaluation of the data from 45,625 participants of the Study on global AGEing and adult
health (SAGE) from these countries showed an increase over baseline of 0.72 (95%CI,
[0.22, 1.22]) in overall WHODAS score (maximum score: 48) and 0.10 (95%CI, [0.02,
0.18]) increase in cognitive domain per 10μg/m3 increase in PM2.5 level. In addition, they
indicated that women and older adults are more at risk of being affected by ambient PM
(38).
Although cognitive decline might be the early manifestation of dementia, not everyone
with cognitive decline will progress to dementia. Therefore, the risk of cognitive decline
does not necessarily indicate the risk of dementia and longitudinal studies are required to
evaluate the risk of dementia in association with air pollutants. In addition, similar as for
other chronic conditions, time-to-event analysis and reporting the hazard ratio (HR) in
cohort studies seems to be the appropriate measure of risk of dementia due to chronic
exposure to high levels of PM.
The association between PM and dementia has been studied in several epidemiological
cohorts. In a population-based cohort study in Taiwan, Jung et al. examined the association
between PM2.5 and AD by using the data from 95,690 individual from the longitudinal
health insurance database (LHID2000). Their study reported a 3% increase in the hazard
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of developing dementia per interquartile range (IQR) of PM2.5 (13.21μg/m3); however, the
association was not statistically significant (HR, 1.03; 95%CI, [0.95, 1.11]) (39).
In 2017, Cacciottolo et al. evaluated the association between exposure to PM 2.5 and
cognitive impairment in 3,647 women from The Women’s Health Initiative Memory Study
(WHIMS) in the United States. Their study showed higher risk of dementia in those
exposed to higher levels of PM2.5 (> 12μg/m3) in comparison to those exposed to lower
levels (HR, 1.92; 95%CI, [1.32, 2.80]). Moreover, they showed that the presence of APOE
ε4 is associated with a higher HR of developing dementia (ε3/3: HR, 1.68; 95%CI, [0.97,
2.92]; ε3/4: HR, 1.91; 95%CI, [1.17, 3.14[; and ε4/4: HR, 3.95; 95%CI, [1.18,13.19]) (40).
Oudin et al. evaluated the association between PM2.5 and dementia in 1,806 individuals
from the Betula project in Sweden. They evaluated the HR for dementia (AD and VaD) for
exposure to PM2.5 due to residential wood burning as well as traffic exhaust. Their results
indicated a significant association between PM2.5 from residential wood burning and
dementia for the group with high exposure levels compared to the group with lower
exposure levels (HR, 1.74; 95%CI, [1.10, 2.75]). In addition, the association between PM2.5
from traffic exhaust and dementia was statistically significant in those exposed to higher
levels of PM2.5 compared to those exposed to lower levels (HR, 1.41 95%CI, [0.97, 2.23])
(41).
In a study by Carey et al., 131,869 residents of the great London, the United Kingdom,
who were registered with a general practice were evaluated for the association of several
air pollutants including traffic-related PM2.5 with dementia. The study indicated an 8%
increase in HR of dementia (HR, 1.08; 95%CI, [1.01 to 1.16]), 13% increase in HR of AD
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(HR, 1.13; 95%CI, [1.02 to 1.26]), an 8% increase in HR of VaD (HR, 1.08; 95%CI, [0.95
to 1.23]), and an 8% increase in HR of non-specific dementia (HR, 1.08; 95%CI, [0.97 to
1.19]) per interquartile change in the traffic-related PM2.5 (0.58μg/m3). These results
indicated a stronger association between PM2.5 and AD than any other subtype of dementia.
In addition, the study did not report any association between night-time noise levels (HR,
1.01; 95%CI, [0.98, 1.03]; per IQR change of night-time noise level [+2.68 dB]) or distance
to major roads (HR, 1.00; 95%CI, [0.95, 1.05]; per IQR change in distance from major
roads [-310m]) and dementia when the regression model was adjusted for other pollutants
(PM2.5 and NO2) (42). This finding might indicate that the main causal pathway to dementia
is affected by air pollutants, and proximity to roads is a factor that increases the chance of
exposure to traffic pollution.
Another study from Sweden, evaluated the exposure to PM2.5 and risk of dementia in 2,927
individuals in the Kungsholmen district of Stockholm using the data from Swedish
National Study on Aging and Care in Kungsholmen (SNAC-K). They reported a
statistically significant risk of developing dementia during the five-year period preceding
the exposure to PM2.5 (HR, 1.54; 95%CI, [1.33, 1.78]; per IQR difference of PM2.5 [0.88
μg/m3]). There was also a statistically significant association between exposure to PM2.5
and incidence of VaD (HR, 1.54; 95%CI, [1.33, 1.78]; per IQR difference of PM 2.5 [0.88
μg/m3]). This study aimed to evaluate the mediatory role of CVD in development of
dementia due to air pollution, and reported stroke as the most important intermediate
condition that might mediate the effect of air pollution in developing dementia (43).
In a case-control study to evaluate the association of PM10 with AD and VaD, Wu et al.
recruited 249 patients with AD, 125 patients with VaD, and 497 controls from three
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teaching hospitals in northern Taiwan. Their study showed approximately four times higher
odds of AD in those exposed to the highest tertile (> 49.23 μg/m3) compared to the lowest
tertile (< 44.95 μg /m3) of PM10 level (OR, 4.17; 95%CI, [2.31, 7.54]). Moreover, the odds
of VaD in the highest tertile was almost 3.5 times of the odds in the lowest tertile (OR,
3.61; 95%CI, [1.67, 7.81]) (44).
In a nested case-control study among the beneficiaries of Taiwan’s National Health
Insurance program (Taiwan’s National Health Insurance Research Database [NHIRD]), Li
et al. could not find any association between VaD and exposure to PM10 five years before
developing dementia (OR, 0.99; 95%CI, [0.98, 1.00]; per 10μg/m3 increase in PM10) (45).
These results are expected because PM10 is usually caught in macrophages and cells of
upper and lower respiratory tract and might not be the main culprit in developing dementia.

1.2.1.1

Studies in Canada

The association between air pollution and dementia was studied in three provinces of
Canada, namely, Ontario, British Columbia, and Quebec.
The first population-based study in Canada was conducted in 2017 by Chen et al. who used
the data from Ontario Population Health and Environment Cohort (ONPHEC) to evaluate
the association of air pollution with incidence of dementia among the Canadian-born
residents of Ontario who were registered in the provincial healthcare plan (OHIP). Of
approximately 2.06 million individuals followed from 2001 to 2013, there was a 3%
increase in HR of dementia (HR, 1.03; 95%CI, [1.02, 1.04]; per IQR difference of PM 2.5
[4.8μg/m3]). In addition, they attributed 2.4% (95%CI, [1.8%, 3.0%]) to PM2.5 alone. When
including cases due to NO2 exposure, 6.1% (95%CI, [4.8%, 7.5%]) of dementia incidence
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could be attributed to air pollution (46). This study suggests the potential importance of
addressing air pollution in preventing a considerable fraction of dementia.
In a population-based retrospective cohort study, Ilango et al. evaluated the mediatory role
of CVD in the association between incidence of dementia and air pollution in residents of
Ontario, Canada, from 2001 to 2013. The study population included 34,391 Canadian-born
Ontario residents who had resided in this province for at least five years. In order to assess
the mediating role of CVD, the investigator considered a three-year exposure period
followed by a five-year lag. During the five-year lag after exposure period, CVD could
occur, but if the patients developed dementia, they would be excluded from the analysis.
Their results indicated around 30% increase in HR of dementia per 10μg/m3 increase in
PM2.5 levels; however, the result was not statistically significant (HR, 1.29; 95%CI, [0.99,
1.64]). On mediation analysis, almost 21% (on multiplicative model) and 4% (on additive
model) of the association of PM2.5 with the incidence of dementia was attributed to causal
pathways related to CVD (47).
In British Columbia, Yuchi et al. evaluated the association between air pollutants and
developing NAD and AD by evaluating 633,949 individuals from the ministry of health
database, using a nested-case-control design to evaluate the association between air
pollution and AD. Their study indicated a nonsignificant association between PM2.5 and
NAD (HR, 1.02; 95%CI, [0.98, 1.05]; per IQR difference of PM2.5 [1.54μg/m3]). In
addition, they did not find association between noise and developing NAD, but reported an
attenuating effect of greenness on the association between exposure to PM2.5 and NAD.
The analysis of nested-case control data indicated no statistically significant association
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between AD and exposure to PM2.5 (OR, 0.90; 95%CI, [0.76, 1.07]; per IQR increase of
1.54 μg/m3] (48).
In a retrospective population-based cohort study, Smargiassi et al. investigated the
association of ambient air pollution with the risk of developing dementia in an open cohort
of 1,807,133 individuals who had resided in Quebec for the previous four years. Their
results showed a 1.5% increase in HR of dementia per 3.90 μg/m3 (IQR) increase in PM2.5
level (HR, 1.02; 95%CI, [1.01, 1.03]). The increase in the HR of dementia was around 5%
per 2.10μg/m3 (IQR) increase in PM2.5 level in the island of Montreal (HR, 1.05; 95%CI,
[1.03, 1.07]). Distance from major roads was negatively associated with the incidence of
dementia (HR, 0.95; 95%CI, [0.94–0.96]; per 150m distance from major roads[IQR]) (49).

1.2.1.2

First-Time Hospitalization With Dementia

In addition to association with total incidence of dementia, the association of air pollution
with incidence of the first-time admission to hospital with the diagnosis of dementia has
been evaluated in a few studies.
The association between long-term exposure to PM2.5 and hospitalization for neurological
disorders including dementia was evaluated in 50 cities of the northern United States. In
this population-based cohort study, Kioumourtzoglou et al. evaluated 9.8 million fee-forservice Medicare enrollees who had exposure to PM2.5 during 1999 through 2010. They
excluded cases that developed dementia during the first two years of enrollment and
included the remaining 7.9 million enrollees for their time-to-event analysis. The study
indicated 15% (HR, 1.15; 95%CI, [1.10, 1.19]) and 7% (HR, 1.07; 95%CI, [1.04, 1.11])
increase in the HR of the first-time hospitalization with dementia and AD per 1μg/m3
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increase in PM2.5 levels, respectively, with similar rates for men and women. In addition,
they found 8% increase in HR of first-time hospitalization with Parkinson’s disease per
1μg/m3 increase in PM2.5 levels (HR, 1.08; 95%CI, [1.04, 1.12]), potentially relating
negative association of air pollution with the central nervous system diseases (50).
In a population-based cohort study in Rome, Italy, Cerza et al. evaluated the association
between air pollution and first-time hospitalization with dementia. They evaluated 350,884
residents of Rome who had completed the population census in 2001 and followed them
until 2013. The study reported no statistically significant association between exposure to
PM2.5 (HR, 0.99; 95%CI, [0.96, 1.02]; per 5μg/m3 increase]) as well as PM10 (HR, 1.00;
95%CI, [0.98, 1.03]; per 10μg/m3 increase]) with the first-time hospitalization with
dementia. Moreover, such an association was not statistically significant for AD and senile
dementia. On the other hand, first-time hospitalization with VaD was significantly
associated with increase in levels of PM2.5 (HR, 1.07; 95%CI, [1.01, 1.12]; per 10μg/m3
increase]) and PM10 (HR, 1.06; 95%CI, [1.02, 1.10]; per 10μg/m3 increase]). In addition,
the association of dementia and its subtypes with distance from high-traffic road was only
significant for AD (51).
Lee et al. evaluated the association between exposure to PM2.5 and hospitalization with
dementia in seven southern states of the United States. In this population-based study, they
evaluated 13.3 million Medicare beneficiaries and followed the participants for 13 years.
The study results indicated that for each 1μg/m3 increase in PM2.5, there was a 5% increase
in HR of the first-time admission with dementia (HR, 1.049; 95%CI, [1.048, 1.051]), 6%
increase in HR of the first-time admission with AD (HR, 1.60; 95%CI, [1.057, 1.062]), and
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9% increase in HR of the first-time admission with VaD (HR, 1.086; 95%CI, [1.082,
1.090]) (52).

1.2.2

Nitrogen oxides

Nitrogen oxide species (NOX) are composed of nitrogen dioxide (NO2) and nitrogen
monoxide (NO). This combination makes it hard to evaluate the association of NOx with
dementia because the combination of NO2 and NO varies from region to region. Nitrogen
dioxide is a traffic-related air pollutant that is generated primarily from vehicles and can
cause detrimental effects on health. The levels of NO2 have been increasing worldwide.
One study showed that the levels of NO2 in 1996 had increased by 2.7 times in 2012 (53).
Animal studies have shown that prenatal exposure to NO2 is associated with problems in
neuromuscular coordination and functional deficits in mice (54). Some studies on pregnant
women who were exposed to air pollutants reported that the effect of NOX on brain might
be due to oxidative stress (55, 56). Evidence also suggests that NO2 disrupts the bloodbrain barrier and leads to neural inflammation in children (57, 58). These studies indicate
that the detrimental effects of NOX can start with intrauterine exposure to nitrogen oxides.
It has been proposed that intrauterine exposure of human fetus to NOX is associated with
poor cognitive outcomes in early childhood.
In a study on 1,889 children whose mother had been exposed to NO2 in the first trimester
of pregnancy, NO2 had inverse association with mental development although the
association was not significant (β, -0.95; 95%CI, [-3.90, 1.89]) (59). Another study on
9,426 children of one to six years old from six European birth cohorts, namely,
GENERATION R (The Netherlands), DUISBURG (Ger many), EDEN (France), GASPII
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(Italy), RHEA (Greece), and INMA (Spain), showed that prenatal exposure to NO2 is
associated with decreased global psychomotor development (β, -0.65; 95%CI, [-1.25, 0.11]). Such an association was not seen with general cognition or language development.
In addition, significant association was not found between cognitive decline and other air
pollutants including, NOx, PM2.5, and PM10 (31). In a population-based study in Spain, 438
mother-child pairs were recruited and children were evaluated around 15 months of age by
the Bayley Scales of Infant Development. The results indicated that for 1μg/m3 increase in
exposures level of NO2 during pregnancy, child’s mental scale score of decreases by 0.29
points (90%CI, [-0.47, -0.11]); however, such an association was not statistically
significant for motor scale score (β, -0.14, 90%CI, [-0.34, 0.06]) (60).
Early life exposure to NO2 is reported to have negative association with child development.
In a cohort study in Malaga Province, Spain, 210 children were followed for a year and
their motor and cognitive development was evaluated at age five with McCarthy Scales of
Children's Abilities (MSCA). Children with higher level of exposure (> 24.75μg/m 3)
showed a decrease in domains of cognitive function including general cognition score (β,
-4.19; 95%CI, [-14.02, 5.64]), quantitative (β, 6.71; 95%CI, [-17.91, 4.49]), working
memory (β, -7.37; 95%CI, [-18.98, 4.24]), and gross motor (β, -8.61; 95%CI, [-18.96,
1.74]) areas. Nonetheless, none of these changes were statistically significant (61).
In a study in Amsterdam, Netherlands, 553 school-age children of nine to 11 years old were
evaluated for the association of exposure to NO2 and transportation noise with cognitive
performance of children at school. The results indicated significant decline in memory span
length at school (χ2, 6.8; df, 1; p-value = 0.01). When the outcome was adjusted for
transportation and aircraft noise, the association remained statistically significant (χ2, 5.9;
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df, 1; p-value = 0.015), indicating the association of exposure to NO2 with memory span
length was independent of surrounding noise (62).
The negative effect of NO2 on cognition continues during adulthood and those exposed to
air pollution later in life are not necessarily spared. In a cross-sectional study in the United
States, 1,496 healthy men and postmenopausal women (mean age, 60.5 y) were evaluated
for the association of air pollutants including NO2 with cognitive function. There was no
statistically significant difference between those exposed to higher levels of NO2 (> 20ppb)
and those exposed to lower levels of NO2 (< 10ppb) in global function or any of the six
measured cognitive domains (executive function, verbal learning, logical memory, visual
memory, semantic memory, and visual processing). However, there was a decrease in
logical memory (β, -0.62; 95%CI, [-1.35, 0.11]), global function (β, -0.32; 95%CI, [-0.92,
0.28]), visual memory (β, -0.26; 95%CI, [-0.97, 0.45]), and semantic memory (β, -0.24;
95%CI, [-0.87, 0.39]) (35). The lack of significance in this study might be due to small
sample size but inverse association of NO2 with domains of cognitive function raises the
possibility of association with further decline in cognitive function and progression to
dementia in the future.
Several studies have investigated the association between NOX and NO2 with dementia and
its subtypes with discrepant results.
In a study by Chang et al. in Taiwan, data of 29,545 individuals (mean age, 61.5 y) from
the NHIRD were evaluated for the association between exposure to NO2 and dementia
from 2000 to 2010. Their results indicated 54% increase in HR in those exposed to the
fourth quartile compared to those exposed to the first quartile of NO2 levels (HR, 1.54;
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95%CI, [1.34, 1.77]). The same increase in HR ratio was seen for male (HR, 1.52; 95%CI,
[1.23, 1.88]) and female subgroups (HR, 1.56; 95%CI, [1.29, 1.87]) indicating no
difference in the risk of dementia between sexes regarding exposure to NO2 (63).
In a population-based cohort study in northern Sweden, Oudin et al. used data of 1,806
individuals from Betula project to evaluate the association between exposure to NOX and
development of AD and VaD. They followed patients for a maximum period of 15 years
(1995-2010) and compared the highest level of exposure (> 26μg/m3) to the lowest level
of exposure (< 9μg/m3) and reported 38% increase in HR of AD (HR, 1.56; 95%CI, [1.29,
1.87]) and 47% increase in HR of VaD (HR, 1.56; 95%CI, [1.29, 1.87]). However, such an
association was not statistically significant for changes in HR per 10μg/m3 increase in level
of NOX (AD: HR, 1.05; 95%CI, [0.97, 1.15]; and VaD: HR, 1.02; 95%CI, [0.92, 1.14])
(64). Using the same database, the authors later evaluated the role of APOE ϵ4 and did not
find any evidence of modifying HR of dementia by this genotype (65). This might indicate
that the association of NOX with cognition and dementia is through another pathway that
does not involve APOE ϵ4. Andersson et al. used the data from the same cohort and
indicated no association between noise and dementia (66), suggesting that the association
of NOX with developing dementia is not modified by noise or in other words, may be due
to air pollution itself rather than traffic-related noise.
In a study by Carey et al. in London, United Kingdom, exposure to NO2 was associated
with dementia, AD, and VaD; however, this association was not statistically significant for
VaD (HR, 1.15; 95%CI, [0.96 to 1.39]; per IQR of 7.5μg/m3). Their study indicated that
per one IQR increase in NO2 levels, HR ratio of dementia and AD increase by 16% (HR,
1.16; 95%CI, [1.05 to 1.28]) and 23% (HR, 1.23; 95%CI, [1.07 to 1.43]), respectively. In
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addition, adjustment for night-time noise had slight modification on the association
between dementia and NO2 (42).
Another study in Sweden evaluated the mediator role of CVD in the causal association
between NOX and dementia. In this study, 2,927 individuals with mean age 71.4 years from
Swedish National Study on Aging and Care in Kungsholmen (SNAC-K) were selected.
The HR of dementia increased by 14% per IQR difference (8.35μg/m3) in mean exposure
to NOX during the last preceding five years at the residential address (HR, 1.14; 95%CI,
[1.01 to 1.29]). Although HR of dementia increased with the presence of heart failure and
ischemic heart disease, the mediation analysis did not show any mediatory role of CVD on
the association of NOX and dementia (OR, 1.11; 95%CI, [0.93, 1.32]) (43).
In a case-control study using NHIRD, Li et al. evaluated the association of NO2 with VaD
in Taiwan. Their results indicated higher odds of VaD in those exposed to higher levels of
NO2 in comparison to the lowest levels five years before the diagnosis of VaD (OR, 2.22;
95%CI, [1.35, 3.65]). On the other hand, there was no statistically significant association
between NO2 levels and dementia when the incremental levels of NO2 were fitted (OR,
1.28; 95%CI, [0.98, 1.66]; per IQR of 4.69ppb)(45).

1.2.2.1

Studies in Canada

In a large population-based cohort study in Ontario, Canada, data of over two million
individuals with the mean age of 66.8 years from Ontario Population Health and
Environment Cohort (ONPHEC) were evaluated for the association between NO2 and
dementia. The study indicated a 10% increase in HR of dementia per IQR (4.8μg/m3)
increase in NO2 levels (HR, 1.10; 95%CI, [1.08, 1.12]) (46). Another study in Montreal,
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Quebec, Canada, evaluated the association of NO2 with the incidence dementia by
evaluating 1.8 million individuals over 65 years of age. The study indicated 1.5% increase
in incidence of dementia per IQR (13.26ppb) change in NO2 levels (HR, 1.015; 95%CI,
[1.007, 1.023]); however, after including PM2.5 levels in the model this became statistically
insignificant (HR, 1.005; 95%CI, [0.994, 1.017])(49). The population-based cohort study
on the association of NOx with NAD in Vancouver, British Columbia, Canada, did not
indicate a significant association between incidence of NAD and exposure to NO2 (HR,
1.02; 95%CI, [0.99, 1.06]; per IQR of 9.1ppb) or NO (HR, 1.00; 95%CI, [0.96, 1.04]; per
IQR of 12ppb). They designed a nested-case-control study within their cohort to evaluate
the association of air pollution with AD and reported a statistically significant lower odds
of exposure to NO2 in cases (OR, 0.84; 95%CI, [0.70, 0.99]; per IQR of 8.96) and no
statistically significant association between NO and AD (OR, 0.91; 95%CI, [0.77, 1.11];
per IQR of 13.68) (48).

1.2.2.2

First-Time Hospitalization With Dementia

A population-based study by Cerza et al. in Rome, Italy reported on the association
between NOX and first-time hospitalization with dementia, and found a marginal increase
in HR of dementia per 20µg/m3 increase in levels of NOX (HR, 1.01; 95%CI, [1.00, 1.02]).
Such an increase in the incidence of the first-time hospitalization was seen with VaD (HR,
1.08; 95%CI, [1.06, 1.10]), but not with AD (HR, 0.96; 95%CI, [0.94, 0.98]). In addition,
they reported a higher HR for dementia in women who were exposed to NOX (HR, 1.10;
95%CI, [1.07, 1.12]) in comparison to men (HR, 1.06; 95%CI, [1.03, 1.09]). Regarding
NO2 levels, there was a statistically significant increase in incidence of first-time
hospitalization with VaD (HR, 1.08; 95%CI, [1.06, 1.10]) and not with AD (HR, 0.91;
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95%CI, [0.89, 0.94]) per 10µg/m3 increase in levels of NO2 (51). Some part of such an
association with air pollution might be due to comorbidities such as CVD that are both
associated with air pollution and are at risk for VaD.

1.2.3

Ozone

Ozone (O3) is also an important pollutant, which is a strong oxidant. Animal and cellular
studies have shown that inhaled O3 has neurotoxic effects (67-69) and may interfere with
the central nervous system and contribute to dementia pathology. The association between
exposure to ambient O3 and cognitive function decline is a recently described phenomenon,
and therefore, few studies have reported on such an association.
In a cross-sectional study, Chen et al. conducted a secondary analysis on Neurobehavioral
Evaluation System-2 (NES2) data of 1,764 adults with mean age of 37.5 (SD,10.9) years
who participated in the Third National Health and Nutrition Examination Survey in 1988–
1991. Their results showed that for every 10ppb increase in annual O3 a consistent increase
was seen in symbol-digit substitution test (SDST; measures coding ability; β, 0.16; 95%CI,
[0.01, 0.23]) and in serial-digit learning test points (SDLT; measures attention and shortterm memory; β, 0.56, 95%CI, [0.07, 1.05]), which was equivalent to 3.5 and 5.3 years
age-related decline in cognitive function (70).
Another cross-sectional study in Los Angeles, California, evaluated the association of air
pollution with six domain-specific cognitive functions and a measure of global cognitive
function in 1,469 middle-aged and older adults (mean age, 60.5 y). Their results indicated
that exposure to an annual mean O3 of 49ppb was associated with decrease in scores of
verbal learning (β, −0.20; 95%CI, [−0.63, 0.2]) and executive function (β, −0.66; 95%CI,
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[−1.35, 0.03]); however, only the decrease in executive function seemed to be associated
with exposure to higher levels of O3. In addition, there was no association between
exposure to O3 and decline in global cognitive function (71).
In a retrospective population-based cohort study on participants of the national Alzheimer’s
Disease Center (ADC) program, the association between exposure to air pollution and
cognitive decline was evaluated. The investigators followed 5,419 individuals for a
maximum of 7.5 years and reported a correlation between exposure to O3 and decline in
cognitive function as there was a significant difference in MMSE score between those
exposed to lowest (30.4ppb to 36.7ppb) and highest levels (40.0ppb to 47.5ppb) of O3 (β,
0.3; 95%CI, [0.1, 0.5]). The authors concluded that exposure to higher levels of O3
accelerates cognitive decline and the presence of APOE ϵ4 accelerates such a decline (72).
In a case-control study in Taiwan, exposure to higher levels of ozone was associated with
almost twice higher odds of developing AD (OR, 2.0; 95%CI, [1.14, 3.50]) and VaD (OR,
2.09; 95%CI, [1.01, 4.33]) when the highest tertile (> 21.56ppb) of exposure was compared
to the lowest tertile (< 20.20ppb). They did not find any evidence of modifying the
association between exposure to O3 and VaD by APOE ϵ4 (44). On the other hand, in the
nested case-control study in Taiwan by Li et al., there was no statistically significant
association between odds of exposure to O3 within five-years before diagnosis and
incidence of dementia (45).
A few cohort studies have evaluated the association between exposure to O3 and HR of
dementia. A population-based cohort study in Taiwan on 95,690 individuals (age ≥ 65 y)
between 2001 to 2010 demonstrated a 6% increase in HR of AD per IQR (9.36ppb) increase
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in O3 levels over baseline (HR, 1.06; 95%CI, [1.00, 1.12]). When the change in O3 (10.91
ppb) during follow-up period was used in the model, the HR of newly diagnosed AD was
increased by 211% (HR, 3.12; 95%CI, [2.92, 3.33]) (39). Their results indicated that the
increasing trend of O3 concentration over the follow-up period was more strongly
associated with incidence of AD than simply mean annual levels of exposure.
In a population-based cohort study in the United Kingdom, a decreasing trend in the
incidence of dementia, AD, and VaD was seen with IQR change (+5.6μg/m3) of O3;
however, the decrease in HR was statistically significant for dementia (HR, 0.84; 95%CI,
[0.75, 0.94]) and AD (HR, 0.78; 95%CI, [0.66, 0.92]), but not for VaD (HR, 0.88; 95%CI,
[0.71, 1.09]) (42).

1.2.3.1

Study in Canada

The only study in Canada that evaluated the association of O3 with dementia is the
population-based cohort study by Chen et al. that included over two million residents of
Ontario. This study did not find any association between exposure to O3 and incidence of
dementia (HR, 0.98; 95%CI, [0.96–1.00]; per IQR of 6.3ppb) (46).

1.2.3.2

First-Time Hospitalization With Dementia

In the study by Cerza et al, the association between exposure to O3 and the first-time
admission to hospital with the diagnosis of dementia was evaluated. Their results indicated
a 6% increase in HR of dementia per 10μg/m3 increase in the mean annual exposure to O3
(HR, 1.06; 95%CI, [1.03–1.08]). However, such an association was not found for AD (HR,
0.98; 95%CI, [0.95–1.02]) and VaD (HR, 1.02; 95%CI, [0.98–1.06]) (51).
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The contradictory results regarding the association of O3 with incidence of dementia
indicate that there might be either a weak association between them or there are other
factors that modify the association of O3 with dementia by either attenuating or
strengthening its effects.

1.2.4

Meta-analyses of the Association of Air Pollution and
Incidence of Dementia

Although numerous systematic reviews have evaluated the association between air
pollution and dementia, the meta-analyses on such an association had been scarce at the
time of formulating this study. Shortcomings of pre-existing meta-analyses include
heterogeneity of assessments and methodology, as well as a limited number of included
studies.
In a systematic review and meta-analysis by Tsai et al. in 2019, the association of PM2.5
with dementia was evaluated. They searched six databases and included four studies (39,
42, 46, 50) in their meta-analysis. Using a random-effects model, they reported that by a
10μg/m3 increase in PM2.5, the incidence of dementia would increase by 326% (HR, 3.26;
95%CI, [1.20, 5.31]). In addition, there was a statistically significant association between
exposure to PM2.5 and incidence of dementia (HR, 4.82; 95%CI, [2.28, 7.36]) (73). The
high pooled HR in this study might be due to using 10 units increase in levels of PM2.5 that
might be beyond what the original data meant to present. Moreover, converting the original
HR to the new increment, i.e. 10μg/m3, might not be accurate and conversion to log and
back to estimates might provide extraordinarily large values for the new estimate. In
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addition, the small number of included studies makes the results prone to favour larger
estimates in the included studies.
Another meta-analysis by Fu et al. (74) on the association between PM2.5 exposure and
neurological disorders in 2019 included five studies in their final model: three in metaanalysis for dementia (46, 50, 75) and three for AD (39, 50) with one of them being
included in both models (50). The study reported an increased HR of dementia (HR, 1.16;
95%CI, [1.07, 1.26]) and AD (HR, 3.26; 95%CI, [0.84, 12.74]) per 10μg/m3 increase PM2.5
levels. In addition to the concerns raised regarding the previous meta-analysis, one of the
included studies (75) had overlapping data with a previous study, but reported the adjusted
HR of dementia for road proximity and therefore, should have been excluded from their
meta-analysis.
Although no completed meta-analyses on the association of other air pollutants, namely,
PM2.5, NOX, and O3, with incidence of dementia or its subtypes in cohort studies, a few are
ongoing at the time of writing this report. The recency of the issue, discrepant reports from
around the world, and lack of an updated meta-analysis suggests that an updated systematic
review and meta-analysis is needed in order to include recent studies with valid methods
of synthesis in order to direct appropriate attention toward the important potential
associations between air pollutants and incidence of dementia based on best available
evidence.

1.3

Objectives

This study aimed to evaluate the association between exposure to three main outdoor air
pollutants, i.e., PM2.5, NOX, and O3, with incidence of dementia or its subtypes by
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evaluating the cohort studies on individuals over 40 years old that have reported HR as
their outcome. The aim of this systematic review and meta-analysis was to evaluate the
association between air pollution with incidence of dementia or its subtypes amongst
individuals over 40 years of age in population-based cohort studies.
The results of this study will be beneficial for scientists who want to conduct studies on the
association of exposure to air pollution and dementia because this study informs them of
the gaps and flaws of the previous studies and guides them to devise future studies. In
addition, the public health authorities and government will be able to evaluate the current
evidence and plan for future actions. Moreover, the citizens of the world will be aware of
the importance of the issue and advocate the policies to decrease air pollution across the
globe.
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Chapter 2
Materials and Methods

2

This study aimed to evaluate the association of dementia with particulate matter 2.5
(PM2.5), nitrogen oxides (NOX), nitrogen dioxide (NO2) and ozone (O3) in a systematic
review and meta-analysis. The protocol of the study was registered in PROSPERO with
the registration number CRD42020219036.

2.1 PECO
In this study, the PECOS (population, exposure, controls, outcome, and study design) was
defined as follows:
P:

Adults over 40 years of age, from any country, whether urban or rural;

E:

Exposure to higher levels of air pollutants, including any one or more of PM2.5, NO x, NO2,
or O3;

C:

Exposure to lower levels of these air pollutants;

O: Incidence of dementia or its subtypes, as reported by hazard ratios (HR); and
S:

Cohort studies (retrospective, prospective, population-based, and registry-based).

The search was not limited to any specific period, or by language.

2.2
2.2.1

Searching Databases and Data Extraction
Information sources

The search strategy was designed and executed in collaboration with medical librarians at
Western University. The search was conducted twice (April 2020 and August 2020). The
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first search was very broad and was performed to identify different types of air pollutants
and study types. Based on the papers that met inclusion criteria during screening of the
results from the first search, we conducted a second search to include more specific terms
for the most commonly-studied pollutants, as well as to further focus the study design
toward cohort studies only. Databases searched included PubMed (1809 - present),
MEDLINE (1946 – present), EMBASE (1947 – present), PsycINFO (1806 – present),
Scopus (1788 – present), and Web of Science (1900 – present). We also searched gray
literature for unpublished work and dissertations. At the data extraction step, we also
contacted some of the authors for additional information or incremental HR when the study
had reported categorical comparisons between high exposure and low exposure. The final
search was completed on August 15, 2020.

2.2.2

Search Strategy

The search strategy included the combination of terms for the outcome and terms for the
exposure. PubMed was searched with the following terms:
("Alzheimer Disease"[Mesh] OR "Dementia"[Mesh] OR alzheimer* OR dementia) AND
("air pollution"[MeSH Terms] "Particulate Matter"[ MeSH Terms] OR "Nitrogen Oxides"[
MeSH Terms] OR "Nitrogen Dioxide"[ MeSH Terms] OR "Nitrous Oxide"[ MeSH Terms]
OR "Ozone"[ MeSH Terms] "Petroleum"[ MeSH Terms] OR "Sulfur Oxides"[ MeSH
Terms] OR (air pollut*) OR (Particulate Matter*) OR (Nitrogen AND (Oxide* OR
dioxide*)) OR (Nitrous AND Oxide*) OR (Ozone) OR (Sulfur AND Oxide*) OR smok*
OR "Cooking"[Mesh] OR cooking* OR "environmental pollution"[MeSH Terms] OR
"Environmental Pollutants"[Mesh Terms] OR "Environmental Exposure"[Mesh] OR
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"traffic-related pollution"[MeSH Terms] OR "Vehicle Emissions"[Mesh Terms] OR
traffic-related OR traffic* OR car* OR Vehicle* OR road* OR transport* OR roadproximity OR "Fossil Fuels"[Mesh] OR "Petroleum Pollution"[Mesh] OR gas OR
gasoline* OR diesel* OR fossil* OR petroleum* OR fuel* OR environment* OR "PM2.5"
or PM10 or NOx OR NO2) AND (pollut* OR exposur* OR emission*).
No filters were used to limit the study by language, study type, or year of publication. The
search terms for other databases are provided in Appendix A.

2.2.3

Study Selection

After completing the search, the results were imported to a reference manager software
(EndNote). Screening was performed by two independent reviewers. First, the duplicated
studies were removed. The title and abstract of the studies were assessed and irrelevant
papers were removed. Then the full texts of the remained papers were examined and
included studies were subjected to data extraction and decision on inclusion in the metaanalysis.

2.2.4

Data Collection Process

Data from included studies were extracted onto an Excel spreadsheet. The pilot form was
used in the first pass on three papers, and after reflection, other items were added or
modified to make the final form. The final form was used by one author for extracting the
data from the rest of the papers. A second investigator read the full texts and verified the
data entry.
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Some of the papers did not use increments of air pollutants in their estimation of HR.
Instead, they compared the highest exposure with the lowest exposure. To have a better
estimation of the HR, we contacted the authors to request more detailed estimates.

2.2.5

Data items

The following data were extracted from each included study: 1) study identifiers: Author
surname, year of publication, type of cohort (prospective or retrospective), and name of the
study or cohort if available; 2) characteristic of the studied population: country,
state/province, and city, included population, age at baseline; 3) information on exposure:
studied pollutants, method of pollutant measurement, exposure period, units of
measurement, and the correlation coefficient between pollutants if more than one pollutant
was studied; 4) information on those with a lower level of exposure; 5) information on the
outcome: follow-up period, the incidence of dementia and its subtypes, age at the time of
diagnosis, applied statistical tests, and hazard ratio according to the increment of pollutants.

2.3

Risk of Bias in Individual Studies

To ascertain the validity of the included studies, the risk of bias was assessed by “Tool to
Assess Risk of Bias in Cohort Studies”. The tool is devised by the CLARITY Group at
McMaster University and comprises eight questions, each of which addresses a different
type of bias and has four possible answers: Definitely yes (low risk of bias); Probably yes,
Probably no, and Definitely no (high risk of bias). According to the answers to each
question, the studies were assigned to high, moderate, or low risk of bias. The risk of bias
assessment was performed independently by two authors. The information was used to

30

prioritize the studies that could be included in the study or should be removed in sensitivity
analysis.

2.4
2.4.1

Statistical Analysis
Summary Measures

The primary outcome measure was HR for incidence dementia and its subtypes, estimated
by the Cox proportional hazard model or its derivatives. This study aimed to evaluate
whether HR for dementia was associated with increasing pollutant levels. When enough
information on the HR of dementia with an increase in levels of air pollutants was not
available, we contacted the authors for additional estimations. The summary measure was
the pooled HR for the incidence of dementia and its subtypes using the random-effects
model.

2.4.2

Converting Units of Measurement and Making the Estimates
Comparable Across Studies

To make the reported estimates by included studies comparable, we made some changes
to the increments of air pollutants. PM2.5 is mainly reported in μg/m3 and hence, the same
unit of measurement was used and if any study had reported the level of PM2.5 in ppb, we
would convert it to μg/m3 (Table 1). To make the studies on PM2.5 comparable, HR and
95% CI were estimated for a 1-unit increase in PM2.5 level. For exposure to NOX, exposure
units were converted to μg/m3 and HR and 95% CI were estimated for a 10-unit increase
in NOX level. For NO2, the unit of exposure in μg/m3 was converted to ppb and HR and
95% CI were estimated for a 10-unit increase in NO2 level. The unit of O3 measurement
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was converted from pbb to μg/m3 and HR estimate and 95% CI were calculated for 10-unit
changes in O3 level.

Table 1. Conversion of the Units of Measurement for Studied Air Pollutants

Levels in ppb

levels in μg/m3

PM2.5

1

1

NOx

1

1.91

NO2

1

1.9125

O3

1

1.9957

Pollutant

The formulae that were used to convert the reported estimates to new estimates based on
the new increments were as follows:
•

For converting the original HR to HR for the new increment of pollutants, the
natural logarithm of the HR was calculated, multiplied by the new increment, and
then divided by the original increment (HRO, original HR; HRN, New HR; IO, old
increment; and IN, new increment):

𝑙𝑛(𝐻𝑅𝑁 ) = 𝑙𝑛(𝐻𝑅𝑂 ) ×

𝐼𝑁
𝐼𝑂
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•

For converting confidence levels to new confidence levels, the following formulae
were used (LCL, lower confidence level; UCL, upper confidence level; O indicates
the old value and N indicates new values for the new increment):
𝛽=

𝑆𝐸 =

𝑙𝑛(𝐻𝑅𝑂 )
𝐼𝑂

𝑙𝑛(𝐿𝐶𝐿𝑂 ) − (𝛽 × 𝐼𝑂 )
1.96 × 𝐼𝑂

95% 𝐿𝐶𝐿𝑁 = 𝑒𝑥𝑝[(𝛽 × 𝐼𝑁 ) − (1.96 × 𝑆𝐸 × 𝐼𝑁 )]
95% 𝑈𝐶𝐿𝑁 = 𝑒𝑥𝑝[(𝛽 × 𝐼𝑁 ) + (1.96 × 𝑆𝐸 × 𝐼𝑁 )]

2.4.3

Meta-analysis and Subgroup Analysis

The meta-analysis for computing pooled HR uses the inverse variance of each study
estimate and therefore, the natural logarithm of HR estimate and standard error of each
included study were introduced to RevMan (Review Manager [Computer program].
Version 5.4. The Cochrane Collaboration, 2020) for calculating the pooled HR estimates.
The studies had included populations from different parts of the world, and they were
clinically heterogeneous with regard to measuring exposure and reported outcome.
Therefore, the random-effects model was used to estimate the pooled HR. The pooled HR
for dementia was estimated separately for each pollutant.
The included studies had reported on different outcomes, namely, the incidence of
dementia, first-time hospitalization with dementia, and subtypes of dementia such as
Alzheimer’s disease (AD), vascular dementia (VaD), and non-Alzheimer dementia (NAD).
The main goal of this meta-analysis was to provide a pooled estimate of HR for studies that
reported on the association between air pollution and dementia, irrespective of the subtype
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of dementia and incidence of hospitalized or non-hospitalized cases of dementia. It is
noteworthy that a recent study has shown that cases that were classified as AD
demonstrated the neuropathological features of other types of dementia in autopsy
examination (5) and therefore, relying on the clinical classification of subtypes of dementia
might be misleading. Moreover, most of the studies had reported on the HR for dementia
as well as for its subtypes which enabled subgroup analysis to evaluate the effect of each
outcome on the pooled HR.
Whenever the study had reported on the HR for dementia, this estimate was used in the
meta-analysis to estimate pooled HR. Whenever they had reported on only subtypes of
dementia, that subtype was included in the analysis as a subgroup. In addition, studies that
reported on the HR of the first-time hospitalization with dementia were included as a
subgroup in the analysis. For each pollutant, HR estimates were calculated for dementia
and its subgroups. Moreover, because the geographic region might affect the incidence of
dementia, the subgroup analysis was performed according to the country/continent where
the study was conducted.
We planned to perform a meta-analysis according to the decades that the exposure
happened and evaluate the trend of changes in pollutants levels and incidence of dementia.
Moreover, we planned to evaluate and compare the association of long-term exposure to
air pollutants with incidence of dementia between males and females.

2.4.4

Assessing Heterogeneity Across Studies

The heterogeneity in effect size across the included studies was quantified by Ι2 and
reported for all the meta-analyses as well as subgroup analyses. Ι2 was interpreted as a
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continuous scale, with higher values inferring higher heterogeneity in effect size across
studies. The advantage of Ι2 to other statistics of assessing heterogeneity such as Q and τ2
is that it is neither sensitive to the number of studies nor to the scale of measurement as it
is the ratio of true heterogeneity to the total variation in observed effects (76).

2.4.5

Risk of bias across studies

For each study, the HR was plotted against its inverse standard error to create a funnel plot,
which was inspected visually for each studied pollutant for visual evidence of potential
publication bias. In addition, “metabias” package in Stata 16SE (StataCorp. 2019. Stata
Statistical Software: Release 16. College Station, TX: StataCorp LLC.) was used to
perform Egger’s test to explore whether there is evidence of a small study-effect indicative
of publication bias, , where a p-value < 0.10 would indicate small studies are missing from
the available set of identified studies.

2.4.6

Additional Analyses

Sensitivity analyses were performed to evaluate robustness of the pooled estimate to the
presence or absence of studies according to predefined variables. Since studies were
heterogeneous regarding the included population and outcome of the study, studies with a
small population were removed one-by-one from the meta-analysis and the effect on the
pooled HR was examined. In addition, studies from certain parts of the world, for instance,
Asia, were removed to examine the robustness of the pooled effect measure to potential
geographic reporting differences. Because some studies had reported outcomes other than
total incidence of dementia, they were also subjected to sensitivity analysis to examine the
effect of differing definitions on the pooled estimates.
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Chapter 3

3

Results

3.1 Study selection
The search was completed on August 14, 2020. Searching PubMed yielded 3,368 papers.
Web of Science and Scopus database search resulted in 1,078 and 164 papers. Medline,
Embase, and APA PsycInfo were accessed through Ovid Lippincott Williams & Wilkins
Total Access Collection and yielded 1,008 papers. After removal of 1,174 duplicate papers,
4,462 papers were assessed for eligibility. Finally, a total of 16 papers were selected for
full text review.
Of the studies collected for full-text review, two papers did not report the incidence of
dementia for increments of NO2 or PM2.5 and were excluded from the meta-analysis. A
study by Oudin et al. on the Betula Cohort in 2016 (64) was excluded from the metaanalysis because an update to the data was published by the same author in 2019 where the
authors examined the role of APOE ϵ4 on the association estimate (65). The reasons for
excluding the papers are described in the PRISMA flow diagram (Fig. 1).
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Figure 1. PRISMA Flow Chart of Review Process and Screening Papers

3.2

Study Characteristics

The characteristics of the included studies are presented in Tables 2 to 5. Finally, a total of
16 population-based cohort studies, all published in English, were included in this
systematic review and 13 were included in the meta-analysis. During the data extraction,
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some information from almost every study was not reported in papers or supplementary
information. In total, authors from eight studies provided additional information for our
analysis. Since the studies were population-based cohorts, access to the data was generally
limited to the time of study, and authors could not add additional information.
The years of recruitment of included cohorts at baseline ranged from 1993 to 2005 and the
endpoint of cohorts ranged from 2003 to 2013. The longest cohorts were from the Betula
project, Umea, Sweden, that followed the population for 17 years (41, 64-66). The studies
were conducted on the population of the following countries: Sweden (5 studies) (41, 43,
64-66), Canada (4 studies) (46-49), the United States (3 studies) (40, 50, 52), Taiwan (2
studies) (39, 63), the United Kingdom (51), and Italy (51).

3.2.1

Population

The total population in the included studies was 28,285,298. Included individuals were ≥
45 years and free of dementia at baseline, for whom the data on exposure to air pollution
was available. Both sexes were included in the included studies except the study by
Cacciottolo et al. (40) that examined the association of PM2.5 with cognitive impairment of
women within the Women’s Health Initiative Memory Study (WHIMS). The mean (SD)
of age at baseline was not reported in some studies and contacting the authors did not yield
additional information for most of them. Moreover, some studies reported age as a
categorical variable and data on baseline age were presented as the frequency of individuals
in the specific age groups (Table 2 and 3).
The latest endpoint in included studies was 2013 which seems reasonable due to the
registry-based design of the cohorts and since such data need time to be collected, cleaned,
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and become available to researchers. In addition, a lengthy time of acquisition and
analyzing such data might cause several years of delay in reporting the results. Therefore,
the studies that were published in 2020 could not provide information on the situation after
2013.
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Table 2.Information on Included Studies a
Author, Year

Study Name

Region, Country

Andersson et
al. (2018)
(66)
Cacciottolo
et al. (2017)
(40)

Betula Cohort

Sweden

WHIMS

US, 48 states

Carey et al.
(2018) (42)

CPRD

Cerza et al.
(2019) (51)
Chang et al.
(2014) (77)

a

Baseline
Age, yb
68.5 (9.4)
Range, 5585;
Range, 65-79

Baseline
Date
1993

London, UK

62.1 (8.4);
range, 50-79

2005

NA

Rome, Italy

74.5 (6.9)

2001

A subset of
NHIRD

Taiwan

61.4 (8.5)

2000

the second test wave T2 (1993–1995), where
sample 3 (S3) was introduced, and sample 1
(S1) was tested for the second time.
Community-dwelling women of ε3/3, ε3/4, and
ε4/4 alleles of European ancestry (primarily
non-Hispanic whites) with complete PM2.5
exposure estimates
Individuals in 75 practices who had been
registered for 1 year continuously with their
practice.
All residents in Rome who were ≥ 65 years old
and filled out the questionnaire of the
population census from 2001.
Individuals ≥ 50 years or older for whom
estimable air pollution data were available but
did not present a history of head injury, stroke,
dementia before 2000

Endpoin
t
2010

2010

2010

2013

2010

Abbreviations: NA, Not available; CPRD, The Clinical Practice Research Datalink; NHIRD, the National Health Insurance Research Database;

and WHIMS, The Women’s Health Initiative Memory Study.
b

1995

Included papulation

Data are presented as mean (SD) and range if available.
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Table 2. Information on Included Studies a (Continued)
Author, Year

Study Name

Region, Country

Chen et al.
(2017) (46)

ONPHEC

Ontario, Canada

Grande et al.
(2020) (43)

SNAC-K

Ilango et al.
(2020) (47)

Jung et al.
(2015) (39)
Kioumourtzog
lou et al.
(2016) (50)
a

Baseline Age,
yb
66.8 (8.2);
Range, 55-85

Baseline
Date
2001

Included papulation

Endpoint

Canadian-born individuals who resided in
Ontario for> 5 years and were registered with
provincial health insurance

2013

Stockholm, Sweden

74.1 (10.7)

2001

Residents of the Kungsholmen district in
central Stockholm from March 21, 2001,
through August 30, 2004, and 60 ≥ years

2013

NA

Ontario, Canada

60.19 (10.56)

1996

2013

Taiwan

NA

2001

US (50 cities)
across the
northeastern US)

75.6 (7.6)

1999

Canadian-born Ontario residents who
participated in the 1996–97 cycle of the
National Population Health Survey (NPHS)
and 2000/01, 2003 and 2005 cycles of the
Canadian Community Health Survey (CCHS).
if they lived in Ontario for at least 5 years and
were ≥45 years or older at the date of survey
(i.e. study baseline).
Individuals from LHID2000
aged ≥65 years at the baseline
Fee-for-service Medicare enrollees (≥ 65 years
old)

LHID2000
NA

2010

Abbreviations: NA, Not available; LHID2000, The longitudinal health insurance database 2000; ONPHEC, Ontario Population Health and

Environment Cohort; and SNAC-K, Swedish National Study on Aging and Care in Kungsholmen.
b

2010

Data are presented as mean (SD) and range if available.
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Table 2. Information on Included Studies a (Continued)
Author, Year

Study Name

Region, Country

Baseline
Age, yb
70.4 (7.3)

Baseline
Date
2000

Included papulation

Endpoint

Beneficiaries of the Medicare fee-for-service
(FFS) plan who were aged ≥ 65 y and resided
in the southeastern part of the United States
between 2000 and 2013.

2013

Lee et al.
(2019) (52)

NA

Seven states of
Southeastern US
(AL, FL, GA, MS,
NC, SC, and, TN)

Oudin et al.
(2016) (64)

Betula
Cohort

Umea municipality,
Sweden

Range, 55-85

1993

Participants who were > 55 years from samples
S1, S2, and S3 gathered at T2

2010

Oudin et al.
(2018) (41)

Betula
Cohort

Umea municipality,
Sweden

Range, 55-85

1993

The second test wave T2 (1993–1995), where
sample 3 (S3) was introduced, and sample 1
(S1) was tested for the 2nd time.

2010

Oudin et al.
(2019) (65)

Betula
Cohort

Umea municipality,
Sweden

69 (NA);
Range, 55-85

1993

The second test wave T2 (1993–1995), where
sample 3 (S3) was introduced, and sample 1
(S1) was tested for the 2nd time.

2010

Smargiassi et
al. (2020) (49)

NA

Quebec, Canada

69.70 (6.76)

2000

Adults ≥ 65 years who lived in Quebec for the
last four years (Open Cohort)

2012

Yuchi et al.
(2020) (48)

NA

Metro Vancouver,
BC

Range, 45-84

1994

All adults aged 45–84 years old who resided in
Metro Vancouver, registered with MSP, and
had lived in Metro Vancouver during the
exposure period

2003

a

Abbreviations: NA, Not available; CPRD, The Clinical Practice Research Datalink

b

Data are presented as mean (SD) and range if available.
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Table 3. Information on Included Studies a
Author, Year

Case Ascertainment/
Diagnosis Criteria

Follow-up
Duration, yb

Follow-up
Period

Statistical
Models

Adjusted covariates

Age at
Diagnosisb

Andersson et al.
(2018) (66)

DSM-IV

NA

1993-2010

Cox
proportional HR

adjusted for baseline age, education, physical
activity, smoking, sex, BMI, WHR, alcohol,
and ApoE4, for baseline medical history of
DM, HTN, and stroke.

NA

Cacciottolo et
al. (2017) (40)

DSM-IV;
The standardized
WHIMS outcome
ascertainment protocols

9.9

1999-2010

Cox
proportional HR

age, geographic region, education, income,
employment status, lifestyle factors (smoking;
alcohol use; physical activities) and clinical
characteristics (use of hormone treatment,
depression, BMI HCL, HTN, DM, and
histories of CVD)

NA

Carey et al.
(2018) (42)

ICD10
Read codes for dementia
within QOF.

6.9

2005-2013

Cox
proportional HR

Age, sex, ethnicity, smoking, alcohol, BMI and
Index of Multiple Deprivation.

77.2 (6.2)

Cerza et al.
(2019) (51)

ICD-9-CM

10.6

2001-2013

Cox
proportional HR

Age, sex, education, place of birth, marital
status, area-based socioeconomic position

77.1 (6.5)

Chang et al.
(2014) (77)

ICD-9-CM

NA

2000-2010

Cox
proportional HR

Age, sex, monthly income, DM, IHD, HTN,
COPD, alcoholism and urbanization

61.4 (8.5)

a

Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; DM, diabetes mellitus; HR, hazard
ratio; HCL, hypercholesterolemia; HTN, hypertension; IHD, ischemic heart disease; NA, not available; WHR, waist-hip ratio; and WHIMS, the Women’s
Health Initiative Memory Study.
b
Data are presented as mean (SD) if available unless stated otherwise
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Table 3. Information on Included Studies a (Continued)
Author, Year

Case Ascertainment/
Diagnosis Criteria

Chen et al.
(2017) (46)

population-based health
administrative databases
with a validated algorithm

Grande et al.
(2020) (43)

Dementia: DSM-IV
AD: according to
NINDS/ADRD criteria
VaD: NINDS and ARN
Patients’ records in the
registry

Ilango et al.
(2020) (47)

Follow-up
Duration, yb

Follow-up
Period

Statistical
Models

Adjusted covariates

Age at
Diagnosisb

10 (3.3)

2001-2013

multilevel
random-effects
Cox
proportional HR

Age, sex, and stratified region, neighborhoodlevel income, education, unemployment rate,
Urban residency and a North/South indicator,
pre-existing brain injury, stroke, DM, HTN,
CAD, heart failure, and arrhythmia, and
Indirectly adjusted for smoking, physical
activity, obesity, and education (Model 5)

73.8 (6.9)

6.01 (2.56)

2001-2013

Cox
proportional HR

Dementia:
83.1 (7.4)

10.6(3.7)

2002-2013

Cox
proportional HR
and an Aalen
additive hazards
model

Age, sex, educational attainment, smoking,
physical inactivity, SES, early retirement,
BMI, depression, baseline MMSE score, and
cardiovascular risk factors
Age, sex, education, marital status, income
quintile, smoking status, BMI, physical
activity, rural residence and northern region;
area level: recent immigrants, unemployment
and education.

NA

Abbreviations: ADRD, Alzheimer’s Disease and Related Disorders Association; ARN, Association Internationale Pour la Recherché et l`Enseignement en
Neurosciences; BMI, body mass index; CAD, coronary heart disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HR, hazard
ratio; HTN, hypertension; IHD, ischemic heart disease; NINDS, the National Institute of Neurological and Communicative Diseases and Stroke; MMSE,
Mini-Mental State Examination; and NA, not available.
b
Data are presented as mean (SD) if available unless stated otherwise
a
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Table 3. Information on Included Studies a (Continued)
Author, Year

Case Ascertainment/
Diagnosis Criteria

Follow-up
Duration, yb

Follow-up
Period

Statistical
Models

Adjusted covariates

Age at
Diagnosisb

Jung et al.
(2015) (39)

MMSE, NINCDSADRDA criteria, ICD-9CM, DSM-IV, Hachinski
ischemic score

NA

2000-2010

Cox
proportional HR

age, gender, income, DM, HTN, MI, stroke,
asthma and COPD

NA

Kioumourtzoglo
u et al. (2016)
(50)

ICD-9-CM

NA

1999–2010

Cox
proportional HR
and Anderson
and Gill
Extension

Age, sex, race, year of follow-up, any previous
admission for CHF, COPD, MI, or DM and
number of days spent in intensive and coronary
care units, ZIP-code level median income as a
proxy for SES.

NA

Lee et al. (2019)
(52)

ICD-9_CM

Median, 6

2000-2013

Extended Cox
Model
(Andersen-Gill)

Age, sex, race, Medicaid eligibility,
educational attainment at the Zip Code level,
and U.S. state of address.

82.2

Oudin et al.
(2016) (64)

DSM-IV

11.4

1993-2010

Cox
proportional HR

Baseline age, education, physical activity,
smoking, sex, BMI, WHR, alcohol, ApoE4,
medical history of DM, HTN, and stroke.

NA

a

Abbreviations: ADRDA, Alzheimer’s Disease and Related Disorders Association; CHF, congestive heart failure; COPD, chronic obstructive pulmonary

disease; DM, diabetes mellitus; HR, hazard ratio; HTN, hypertension; MI, myocardial infarction; MMSE, Mini-Mental State Examination; NINCDS, the
National Institute of Neurological and Communicative Diseases and Stroke; NA, not available; SES, socioeconomic status.
b

Data are presented as mean (SD) if available unless stated otherwise

45

Table 3. Information on Included Studies a (Continued)
Author, Year

Case Ascertainment/
Diagnosis Criteria

Oudin et al.
(2018) (41)

DSM-IV

Oudin et al.
(2019) (65)

Registry files
ICD-9 and ICD-10

Smargiassi et al.
(2020) (49)

ICD-9 or ICD-10

a

Follow-up
Duration, yb

Follow-up
Period

Statistical
Models

Adjusted covariates

Age at
Diagnosisb

11.4

1993-2010

Cox
proportional HR

NA

7.3(4.3)

2000-2013

extended Cox
proportional HR

Age, Education, physical activity, smoking,
sex, BMI, WHR, and alcohol consumption,
APOE4
stratified for sex, adjusted for calendar year,
and indexes of social and material deprivation.

NA

1999-2003

Cox
proportional HR

Median, 76

Abbreviation: BMI, body mass index; CAD, coronary heart disease; CHF, congestive heart failure; DM, diabetes mellitus; HR, hazard ratio; HTN,

hypertension; NA, not available; TBI, traumatic brain injury; WHR, waist-hip-ratio
b

Age, sex, comorbidities (TBI, DM, HTN,
stroke, CAD, CHF, and arrhythmia),
household income, education and ethnicity

NA

Data are presented as mean (SD) if available unless stated otherwise
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3.2.2

Exposure

Among the included studies, four, three, and one exclusively reported on exposure to PM2.5
(40, 41, 50, 52), NOX (64-66), and NO2 (63), respectively. Other studies reported on two
or more exposures and few studies reported correlation coefficient between pollutants.
Exposure was measured through various methods. For most of the studies, a land use
regression (LUR) model was used to assign the concentration of the pollutants to the postal
code of the residents. These measurements have their limitations and assigning the
pollutant level to a specific area was not similar among studies. Some studies used
information from satellites along with data from pollutant measuring stations to estimate
the population exposure in each residential area (Table 4). While the exposure period was
not clearly separated from the follow-up period in most of the studies, a study by Lee et al.
on the association of PM2.5 and dementia considered a five-year-lag before developing
dementia as the exposure period (52). Additionally, Ilango et al. examined the mediating
role of cardiovascular diseases (CVD) in developing dementia after exposure to No2 and/or
PM2.5. They considered a three-year exposure before a five-year lag for developing
dementia during which the CVD could develop (47).

3.2.3

Controls

In all included studies, the incidence of dementia was evaluated against those who had
not developed dementia by Cox proportional hazard regression model or its derivatives
(Table 3). Since almost everyone in the population was exposed to some degree to the air
pollutants, some studies categorized the exposure according to the level of exposure.
When the exposure level was used as a categorical variable in the regression models and
the hazard ratio (HR) for unit(s) increase in air pollutants was not available, the authors
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were contacted for an estimate of HR per increments of pollutants and four authors
responded and sent the requested estimates The information on two studies that had
reported the categorical levels of exposure (40, 63) could not be obtained and therefore,
they were excluded from the meta-analysis. Overall, eight authors responded to our
request for additional information about age at baseline, duration of follow-up, and
exposure period.
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Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a
Author, Year

Pollutants

Andersson et al.
(2018) (66)

NOx

LUR model based on measurements during a four-week long period between
November 2009 and June 2010.

Cacciottolo et al.
(2017) (40)

PM2.5

A spatiotemporal model that integrated AQS and the output of chemical transport
models to at all WHIMS residential locations in 1999–2010.

1999-2010

Carey et al. (2018)
(42)

NO2,
PM2.5
O3

Modelled annual concentrations for air pollutants were estimated using the KCL
urban dispersion modelling system at a resolution of 20×20 m from 2004-2010

2004-2010

Cerza et al. (2019)
(51)

PM2.5
NO2
NOX
O3
NO2

LUR models.
PM2.5 was measured in 20 sites, and NOx was measured in 40 sites in three twoweek periods during 2010.
To estimate summer daily ozone (8 h) exposure FARM was used.
Data from 74 ambient air quality monitoring stations were used. Yearly average
concentrations of pollutants were calculated from the baseline to the end of the
study

2001-2013

Chang et al. (2014)
(77)

a

Measures of Exposure

Exposure
period
1993-2010

2000-2010

Abbreviations: AQS, air quality system; FARM, Flexible Air quality Regional Model; LUR, land use regression; and WHIMS, the
Women’s Health Initiative Memory Study

49

Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a (continued)

a

Author, Year

Pollutants

Measures of Exposure

Exposure period

Chen et al. (2017)
(46)

PM2.5
NO2
O3

1994-2013

Grande et al.
(2020) (43)

PM2.5
NOX

PM2.5: information from satellite observations in combination with outputs from
a global atmospheric chemistry transport model (GEOS-Chem CTM) producing
an annual mean concentration of PM2.5 (1× 1 km) yearly between 1998 and
2012.
NO2: a national LUR model using NO2 observations at fixed-site monitors from
National Air Pollution Surveillance Network.
O3: Environment and Climate Change Canada has produced a long-term annual
mean warm-season exposure surface of O3 (21 ×21 km) covering Canada
between 2002 and 2009.
Annual mean air pollution levels from local sources were calculated using
emission inventories describing traffic and nontraffic sources for 1990, 1995,
2000, 2005, and 2011. Annual mean levels of PM2.5 and NOX for 1990 through
2011 were obtained from linear interpolation during the 4 years between each
model simulation, and levels for 2012 and 2013 were set as of 2011.

Abbreviation: LUR, land use regression

5 years
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Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a (continued)
Author, Year

Pollutants

Measures of Exposure

Ilango et al. (2020) (47)

NO2
PM2.5

used previously estimated mean measurements of NO2 and PM2.5 at a spatial
resolution of about 1 x 1km for each year between 1993 and 2013.
Calculated averages of pollutant measurements over the three years leading
up to the time of baseline survey completion.

Jung et al. (2015) (39)

PM2.5
O3

Hourly PM10 and O3 data available from 70 Taiwan EPA monitoring stations
on Taiwan’s main island from 2000 through 2010.
The mean ratio between PM2.5 and PM10 during 2006-2010 was used to
estimate the concentrations of PM2.5 from 2000 to 2006.

Kioumourtzoglou et al.
(2016) (50)

PM2.5

Lee et al. (2019) (52)

PM2.5

PM2.5data obtained from the U.S. EPA and AQS database (U.S. EPA 2013).
Annual PM2.5 averages within each city were estimated from 1999 through
2010.
The observations from a satellite with a 1-km resolution were calibrated to
PM2.5 data from ground monitors

a

Exposure period
The 3-year average
of pollutants with a
5-year lag before
dementia. CVD
could develop in
the 5-year period
1999-2010

1999-2010

5 years before Dx

Abbreviations: AQS, air quality system; CVD, cardiovascular diseases; Dx, diagnosis; and EPA, Environmental Protection Agency
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Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a (continued)
Author, Year

Pollutants

Measures of Exposure

Exposure period

Oudin et al. (2016) (64)

NOX

LUR model for Umeå to estimate the annual average levels
of nitrogen oxides (NOX).

Annual mean NOx concentration
(estimated for 2009–2010) was used
as a marker for long-term exposure
to air pollution

Oudin et al. (2018) (41)

PM2.5

They used data on the annual mean concentration of PM2.5
for 1990, 2000 and 2010, calculated by the Swedish
Meteorological and Hydrological Institute (SMHI).

1993-2010
measured at 1990, 2000, 2010

Oudin et al. (2019) (65)

NOX

A LUR model was used to estimate the concentration at the
residence of each study person.

Annual mean NOx concentration
(estimated for 2009–2010) was used
as a marker for long-term exposure
to air pollution

Smargiassi et al. (2020)
(49)

PM2.5
NO2

NO2: a national LUR model
PM2.5: satellite imagery

2000-2012

Yuchi et al. (2020) (48)

PM2.5
NO2
NO

LUR models specific to Metro Vancouver were applied to
estimate exposure to pollutants. monthly predicted air
pollution concentrations were averaged to obtain air
pollutant concentrations over the entire exposure period.

1994-1998

a

Abbreviation: LUR, land use regression.

(January 1994–December 1998)
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3.2.4

Outcome

Case ascertainment was not consistent among the studies. All cohorts were retrospective
and therefore, the main method of categorizing dementia or its subtypes as a diagnosis was
through examining administrative database or electronic health record diagnosis. In this
sense, most of the studies used different versions of the International Classification of
Diseases (ICD) according to the year of the study and development of codes. Other studies
used DSM-IV criteria to diagnose dementia, alone or in combination with other tools such
as ICD, MMSE, Hachinski ischemic score, or other validated algorithms (Table 3).
The total incidence of dementia and its subtypes, namely, Alzheimer’s disease (AD),
vascular dementia (VaD), and non-Alzheimer dementia (NAD), was 2,381,422 (11.88%)
in a total population of 28,285,298. Some studies reported the incidence of AD and/or VaD
as the sole outcome or as a subgroup of dementia with a total of 848,702 cases of AD and
166,235 cases of VaD. Three studies reported the incidence of first-time hospitalization
with dementia (50-52). The total incidence of the first first-time hospitalization with
dementia was 1,634,610 (including 846,046 cases of AD and 165,420 cases of VaD) in a
total population of 23,478,591. The total included population across all included studies
was 28,285,298, and approximately 83% of the included population in this systematic
review was from these three studies on the first-time hospitalization with dementia (Table
5).
It is noteworthy that four studies from Sweden (41, 64-66) used data from the Betula
project, a population-based longitudinal study on memory, health, and ageing, and reported
incidence of dementia and subtypes in association with exposure to different pollutants.
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Hence, there might be overlap among included populations and reported cases of dementia
and for calculating the total population and incidence of dementia and its subtypes, only
the largest sample size and incidence of dementia were included.
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Table 5. Population Included in Each Study and Number of Incidence Cases a
Author, Year
Andersson et al. (2018) (66)
Cacciottolo et al. (2017) (40)
Carey et al. (2018) (42)
Cerza et al. (2019) (51)
Chang et al. (2014) (77)
Chen et al. (2017) (46)
Grande et al. (2020) (43)
Ilango et al. (2020) (47)
Jung et al. (2015) (39)
Kioumourtzoglou et al. (2016) (50)
Lee et al. (2019) (52)
Oudin et al. (2016) (64)
Oudin et al. (2018) (41)
Oudin et al. (2019) (65)
Smargiassi, 2020 (49)
Quebec
Island of Montreal
Yuchi et al. (2020) (48)

Included Population
(n)

Male, n (%)

1721
3647
130,978
350,884
29,547
2,066,639
2,927
34,391
95,690
9,817,806
13,309,901
1806
1,806
1,567
1,807,133
457,768
633,949

Outcome
Dementia

AD

Vad

NAD

985 (57%)
0
65,130 (49.7%)
145,994 (42%)
13606 (46%)
966,246 (46.8%)
1082 (37%)
14,555 (42%)
43.70%
5,871,658 (54.1%)
773 (43%)
773 (43%)
687 (44)

302b
173
2181
21,548
1,720
257,816
364
2,559
203,463
1,409,599
-

191
848
7,669
218
1,399
266,725
571,652
191
191
173
-

111
634
7,494
70
157,926
111
111
102
-

146
-

44.91%
41.16%
300,192 (47%)

199,826
51,815
-

-

-

Abbreviations: AD, Alzheimer’s disease; HR, hazard ratio; NAD, non-Alzheimer dementia; and VaD, vascular dementia.
Alzheimer’s disease and vascular dementia
c
First-time Hospitalized with the diagnosis of dementia and its subtypes.
a

b

13,170
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3.3

Risk of Bias Within Studies

Risk of bias was assessed in each study using the “Tool to Assess Risk of Bias in Cohort
Studies” (78). According to our assessment, included studies had assigned the exposure to
the residential address and the methods used for estimating exposure were not accurate.
Therefore, all the studies bear some uncertainty in the assessment of exposure. Since the
registry data was used to ascertain cases and assigning the codes might not be accurate,
absence of the dementia at baseline and ascertainment of cases might not be free of error.
This might also cause some misclassification of both cases and controls. In addition, each
study adjusted for different variables at analysis level and some of the risk factors for the
outcome were not adjusted for in the statistical analysis. The exact period and level of
exposure that can cause dementia as well as the period between exposure and the clinical
presentation of dementia is not fully known and the adequacy of the follow-up period
would be uncertain. Hence, studies had an intermediate risk of bias in most of the assessed
domains. (Table 6).
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Table 6. The Assessment of the Risk of Bias Using Tool to Assess Risk of Bias in Cohort
Studies a
Authors, year
Andersson et al., 2018 (66)

1

2

3

Domains of Bias †
4
5

6

7

8

Cacciottolo et al., 2017 (40)
Carey et al., 2018 (42)
Cerza et al., 2019 (51)
Chang et al., 2014 (77)
Chen et al., 2017 (46)
Grande et al., 2020 (43)
Ilango et al., 2020 (47)
Jung et al., 2015 (39)
Kioumourtzoglou et al., 2016 (50)
Lee et al., 2019 (52)
Oudin et al., 2016 (64)
Oudin et al. , 2018 (41)
Oudin et al., 2019, (65)
Smargiassi, 2020 (49)
Yuchi et al., 2020 (48)
⁕

Each question has four choices: Definitely yes, low risk of bias; Green; Probably yes, high
intermediate risk, yellow; Probably no, low intermediate risk, pink; and Definitely no, high risk of bias;
red.
†
Domains of bias; the Questions to be answered were:
1. Was selection of exposed and non-exposed cohorts drawn from the same population?
2. Can we be confident in the assessment of exposure?
3. Can we be confident that the outcome of interest was not present at start of study?
4. Did the study match exposed and unexposed for all variables that are associated with the outcome
of interest or did the statistical analysis adjust for these prognostic variables?
5. Can we be confident in the assessment of the presence or absence of prognostic factors?
6. Can we be confident in the assessment of outcome?
7. Was the follow up of cohorts adequate?
8. Were co-interventions similar between groups?
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3.4

Results of Individual Studies

Results of the individual studies are presented in Tables 7 to 10. All the included studies
had used the Cox proportional hazard model or its derivatives to produce HR estimates. In
addition, the level of exposure was not the same among the included studies. Therefore,
some studies dichotomized and compared the higher level of exposure with a lower level
of exposure or categorized the exposure into tertiles or quartiles for comparing different
levels of exposure. Since most of the studies had reported HR in association with an
increase in a certain level of pollutants, e.g., interquartile range (IQR), we excluded studies
that did not report HR for incremental changes in pollutants if the authors did not or could
not provide the estimates when they were contacted. Therefore, studies by Chang et al. (63)
and Cacciottolo et al. (40) were removed from the meta-analysis.
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Table 7. Hazard Ratio and 95% Confidence Interval of Dementia and Its Subtypes Reported per Increment of PM2.5 in the
Included Studies a
Increment,
𝛍g/m3

HR (95%CI)
Dementia

AD

VaD

NAD

b

1.92 (1.32, 2.80)

-

-

-

Carey et al. (2018) (42)

0.95c

1.07 (1.02, 1.12)

1.10 (1.02, 1.18)

1.06 (0.97, 1.16)

-

Chen et al. (2017) (46)

4.8

1.03 (1.02, 1.04)

-

-

-

Grande et al. (2020) (43)

0.88c

1.54 (1.33, 1.78)

-

1.66 (1.38, 1.99)

-

Ilango et al. (2020) (47)

10

1.29 (0.99, 1.64)

-

-

-

13.21c

-

Author, year
Cacciottolo et al. (2017) (40)

Jung et al. (2015) (39)

1.03 (0.95, 1.11)

-

-

1

1.14 (0.59, 2.23)

d

-

-

-

Smargiassi et al. (2020) (49)

3.9c

1.02 (1.01, 1.03)

-

-

-

Yuchi et al. (2020) (48)

1.54c

-

-

-

1.02 (0.980, 1.050)

Cerza et al. (2019) (51)

5

0.99 (0.96, 1.02)

0.91 (0.85, 0.97)

1.07 (1.01, 1.12)

-

Kioumourtzoglou et al. (2016) (50)

1

1.15 (1.10, 1.19)

1.07 (1.04, 1.11)

-

-

Lee et al. (2019) (52)

1

1.049 (1.048, 1.051)

1.06 (1.057, 1.062)

1.086 (1.082, 1.09)

-

Oudin et al. (2018) (41)

First-time Hospitalization

a

Abbreviations: HR, hazard ratio; AD, Alzheimer’s disease; VaD, vascular dementia; and non-Alzheimer dementia.

b

Higher level of exposure (>12 𝛍g/m3) compared to the lower level; the study was excluded from the meta-analysis.

c

Per interquartile change in PM2.5.

d

Alzheimer’s disease and vascular dementia
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Table 8. Hazard Ratio and 95% Confidence Interval of Dementia and Its Subtypes Reported per Increment of NOx in the
Included Studies a
HR (95%CI)
Author, year
Andersson et al. (2018) (66)
Grande et al. (2020) (43)

Increment,
𝛍g/m3

Dementia

AD

VaD

b

1.41 (0.97, 2.03)

-

-

8.35 c

1.14 (1.01, 1.29)

-

1.09 (0.98, 1.3)

1.05 (0.97, 1.15)

1.02 (0.92, 1.14)

Oudin et al. (2016) (64)

10

1.05 (0.98, 1.12)

Oudin et al. (2019) (65)

10

1.03 (0.97, 1.1)

1.04 (0.96, 1.13)

-

20

1.01 (1, 1.02)

0.96 (0.94, 0.98)

1.08 (1.06, 1.1)

d

First-time Hospitalization
Cerza et al. (2019) (51)
a

Abbreviations: AD, Alzheimer’s disease; HR, hazard ratio; and VaD, vascular dementia.

b

Higher level of exposure (>26 𝛍g/m3) compared to the lower level (<9 𝛍g/m3); the HR (95% CI) for a 1-unit

increase in NOx level was provided by the author.
c

Per Interquartile change.

d

Alzheimer’s disease and vascular dementia
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Table 9. Hazard Ratio and 95% Confidence Interval of Dementia and its Subtypes Reported per Increments of NO2 in the
Included Studies a
HR (95%CI)
Author, year

Increment

Dementia

AD

VaD

NAD

Carey et al. (2018) (42)

7.47 μg/m3 b

1.16 (1.05, 1.28)

1.23 (1.07, 1.43)

1.15 (0.96, 1.39)

-

Chang et al. (2014) (77)

c

1.54 (1.34, 1.77)

-

-

-

Chen et al. (2017) (46)

14.2 ppb

1.1 (1.08, 1.12)

-

-

-

Ilango et al. (2020) (47)

5 ppb

1.1 (0.99, 1.19)

-

-

-

1.015 (1.007, 1.023)

-

-

-

-

-

-

1.02 (0.99, 1.06)

0.98 (0.96, 0.99)

0.91 (0.89, 0.94)

1.05 (1.03, 1.07)

-

Smargiassi et al. (2020) (49)
Yuchi et al. (2020) (48)

13.26 ppbb
9.06 ppb

b

First-time Hospitalization
Cerza et al. (2019) (51)

10 𝛍g/m3

a

Abbreviations: HR, hazard ratio; AD, Alzheimer’s disease; and VaD, vascular dementia.

b

Per interquartile change in NO2.

c

Higher level of exposure (>26 𝛍g/m3) compared to the lower level (<9 𝛍g/m3).

d

Alzheimer’s disease and vascular dementia
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Table 10. Hazard Ratio and 95% Confidence Interval of Dementia and its Subtypes Reported per Increment of O3 in the
Included Studies a
HR (95%CI)
Author, year

Increment

Dementia

AD

VaD

Carey et al. (2018) (42)

5.56 μg/m3 b

0.84 (0.75, 0.94)

0.78 (0.66, 0.92)

0.88 (0.71, 1.09)

Chen et al. (2017) (46)

6.3 ppb

0.98 (0.96, 1.00)

-

-

-

1.06 (1.00, 1.12)

-

1.06 (1.03, 1.08)

0.98 (0.95, 1.02)

1.02 (0.98, 1.06)

b

Jung et al. (2015) (39)

9.63 ppb

First-time Hospitalization
Cerza et al. (2019) (51)

10 𝛍g/m3

a

Abbreviations: HR, hazard ratio; AD, Alzheimer’s disease; and VaD, vascular dementia.

b

Per interquartile change in O3.
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3.5
3.5.1

Synthesis of Results
Particulate Matter with Diameter < 2.5𝛍

The HR of dementia and/or its subtypes in association with PM2.5 was reported in 12
studies. The study by Cacciottolo et al. (40) was excluded because it did not report the HR
of dementia in association with a unit increase of PM2.5. Dementia was the reported
outcome in nine studies, four of which also reported on VaD as the outcome. In addition,
AD was reported in five studies, and was the only reported outcome in one study (39).
Moreover, a study by Yuchi et al. reported NAD as the only outcome (48). Three studies
reported on first-time hospitalization with dementia (50-52) and because of their large
sample size, they affected the pooled estimate significantly.
The pooled HR showed a statistically significant association between PM2.5 and incidence
of dementia, either first-time hospitalized or any case of dementia (HR, 1.04; 95%CI: [1.02,
1.06]; Ι2 = 100%). The largest estimate was seen in the subgroup that reported on the
incidence of first-time hospitalization with dementia (HR, 1.06; 95%CI: [1.01, 1.10]; Ι2 =
99%), which was expected because they were larger registry-based studies and comprised
almost 80% of the study population. Such an association was statistically significant for
studies that reported on incidence of dementia (HR, 1.02; 95%CI: [1.01, 1.03]; Ι2 = 95%).
The p-value for subgroup interaction was significant (p-value = 0.02), indicating that the
effect sizes for these subgroups are statistically different from one another, and indicating
that differences in effect size were found according to definition of dementia.
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Figure 2. Subgroup analysis of hazard ratio per 1μg/m3 increase in PM2.5 level for all
the studies that reported on the association of PM2.5 with incidence of any type of
dementia and the incidence of the first-time hospitalization with dementia
To further evaluate the effect of subtype of dementia on the pooled estimate, the studies
that reported on AD, VaD, and NAD either as the main outcome or as a subgroup of
dementia were included in the meta-analysis, while the studies that had reported only on
dementia as the sole outcome were excluded. There was a significant association between
exposure to PM2.5 and incidence of subtypes of dementia (HR, 1.06; 95%CI: [1.03, 1.08];
Ι2 = 99%); however, the association was statistically significant for VaD (HR, 1.15; 95%CI:
[1.08, 1.23]; Ι2 = 99%) but not for the incidence of AD (HR, 1.04; 95%CI: [1.00, 1.08]; Ι2
= 99%) (Fig. 3).
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The p-value for subgroup interaction was significant (p-value = 0.001), indicating that the
effect sizes for these subgroups are statistically different from one another, and indicating
that differences in effect size were found according to definition of dementia.

Figure 3. Subgroup analysis of hazard ratio per 1μg/m 3 increase in PM2.5 for the
studies that reported on the association of PM2.5 with Alzheimer’s disease, vascular
dementia, and non-Alzheimer dementia
The pooled HR was also estimated for studies from North America (six studies) (46-50,
52), Europe (four studies) (41-43, 51), and Asia (one study) (39) to see if geographical
region might have an effect on the estimates. Pooled estimates indicated a significant
association between exposure to PM2.5 and incidence of dementia in studies from North
America (HR, 1.03; 95%CI: [1.01, 1.06]; Ι2 = 100%). On the other hand, although the
pooled estimate of the studies in Europe (United Kingdom, Italy, and Sweden) was large,
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the confidence intervals were wide and the association was not statistically significant (HR,
1.22; 95%CI: [0.94, 1.58]; Ι2 = 97%; Fig. 4).
The p-value for subgroup interaction was significant (p-value = 0.02), indicating that the
effect sizes for these subgroups are statistically different from one another, and indicating
that differences in effect size were found according to the continent where the study was
performed.

Figure 4. Subgroup analysis of hazard ratio per 1μg/m 3 increase in PM2.5 for the
studies from different continents that reported on the association of PM2.5 with any
type of dementia

3.5.2

Nitrogen Oxides

A total of four studies evaluated the association of exposure to NOX with the incidence of
dementia (43, 51, 65, 66); however, one of the studies was the update to a previous study
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(64, 65) and we only included one of them in the meta-analysis. In addition, one study
reported first-time hospitalization with dementia as its outcome and was included in the
meta-analysis as a subgroup. The study by Andersson et al. (66) measured NOX in μg/m3
and compared the highest levels of exposure with the lowest levels of exposure, and the
author provided the HR estimate for one-unit and 10-unit increase in NOX level when he
was contacted. The conversion of ppb to μg/m3 is challenging because the exact proportion
of nitric oxide and NO2 should be known. Unfortunately, such information was not
available and the conversion of ppb to μg/m3 for Andersson et al. was not possible due to
inaccurate data based on general knowledge about the coefficient of conversion that was
already reported. Since none of the individual estimates indicated a significant association
between NOX and incidence dementia, the pooled estimate was also expected to show no
statistically significant association (HR, 1.04; 95%CI: [0.98, 1.10]; Ι2 = 57%) either when
the study by Andersson et al. was added (Fig. 5) or when the study by Cerza et al. (51) that
reported on the first-time Hospitalization was introduced as a subgroup (Fig. 6).
The p-value for subgroup interaction was non-significant (p-value = 0.13; Fig. 6),
indicating that the effect sizes for these subgroups are not statistically different from one
another, and indicating that differences in effect size were not found according to definition
of dementia.
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Figure 5. Pooled hazard ratio per 10 μg/m3 increase in NOX for the studies that
reported on the association of NOX with dementia

Figure 6. Pooled hazard ratio per 10μg/m3 increase in NOX for the studies that
reported on the association of NOX with dementia when study on the first-time
hospitalization was introduced as a subgroup
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3.5.3

Nitrogen Dioxide

A total of seven studies reported on exposure to NO2 (42, 46-49, 51, 63). Six studies
reported on dementia (42, 46, 47, 49, 51, 63) and one study on NAD (48). In addition, the
study by Chang et al. did not provide the HR for a unit increase in NO2 and was not included
in the meta-analysis. (63). Moreover, only two studies reported on the incidence o AD and
VaD as subtypes of dementia (42, 51). The pooled HR was estimated by including studies
on the first-time hospitalization with dementia and a study that reported on the incidence
of NAD as subgroups (Fig. 7). Although there was a significant association between the
incidence of dementia and exposure to NO2 (HR, 1.07; 95%CI: [1.02, 1.12]; Ι2 = 96%),
such an association did not exist when studies that reported on NAD and first-time
hospitalization with dementia were included in the meta-analysis (HR, 1.04; 95%CI: [1.00,
1.08]; Ι2 = 96%).
The p-value for subgroup interaction was significant (p-value < 0.001), indicating that the
effect sizes for these subgroups are statistically different from one another, and indicating
that differences in effect size were found according to definition of dementia.
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Figure 7. Subgroup analysis of hazard ratio per 10 μg/m 3 increase in NO2 for the
studies that reported on the association of NO2 with incidence of dementia, first-time
hospitalization with dementia, and non-Alzheimer dementia

3.5.4

Ozone

The HR for association between O3 and dementia was reported in four studies (39, 42, 46,
51), one of which reported only on the association with AD (39). Only the study by Creza
et al. reported a significant association between exposure to O3 and incidence of first-time
hospitalization with dementia (51). The pooled HR was estimated for all four studies where
the study by Creza et al. on the first-time hospitalization with dementia and the study by
Jung et al. on the incidence of AD (39) were introduced to the model as subgroups (Fig.
8). No statistically significant association was found between exposure to O3 and dementia
for two studies that reported on dementia (HR, 0.87; 95%CI: [0.70, 1.09]; Ι2 = 54%) and
for all included studies (HR, 1.01; 95%CI: [0.91, 1.11]; Ι2 = 82%). The p-value for
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subgroup interaction was non-significant (p-value = 0.12), indicating that the effect sizes
for these subgroups are not statistically different from one another, and indicating that
differences in effect size were not found according to definition dementia.

Figure 8. Subgroup analysis of hazard ratio per 10 μg/m3 increase in O3 for the studies
that reported on the association of O3 with incidence of dementia, first-time
hospitalization with dementia, and Alzheimer’s disease
Two studies reported on the incidence of AD and VaD as a subgroup of dementia (42, 51).
The pooled estimate for these two subgroups did not yield any statistically significant
association between exposure to O3 and the incidence of AD (HR, 1.02; 95%CI: [0.88,
1.17] Ι2 = 75%) or VaD (HR, 1.02; 95%CI: [0.98, 1.06]; Ι2 = 0%) (Fig. 9).
The p-value for subgroup interaction was significant (p-value = 1.0), indicating that the
effect sizes for these subgroups are not statistically different from one another, and
indicating that differences in effect size were not found according to definition of dementia.
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Figure 9. Subgroup analysis of hazard ratio per 10 μg/m3 increase in O3 for the studies
that reported on the association of O3 with incidence of Alzheimer’s disease and
vascular dementia

3.6

Heterogeneity Across Included Studies

Significant heterogeneity was found among studies that reported on the association
between exposure to PM2.5 and incidence of dementia (Ι2 = 95%), studies that reported on
the incidence of the first-time hospitalization with dementia (Ι2 = 99%), and when all
studies were included in the meta-analysis of the association between PM2.5 and incidence
of dementia (Ι2 = 100%).
There was also evidence of heterogeneity across studies that evaluated the association of
dementia and its subtypes with the exposure to NO2 (Ι2 = 96%) and O3 (Ι2 = 82%). There
was also a moderate heterogeneity among studies that evaluated the association of
dementia with exposure to NOX (Ι2 = 57%).
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3.7

Risk of Bias Across Studies

To evaluate the publication bias, funnel plots were created and evaluated (Fig. 10-13). It is
noteworthy that the funnel could not be forced on the plots because of the small number of
included studies. The plot indicated asymmetry in all studied pollutants. While the graphs
indicate potential asymmetry for the association of each pollutant with dementia, the small
number of studies makes it difficult to rule in or rule out publication bias. Overall, it appears
that small negative studies are missing from the funnel plot, indicating potential publication
bias.

Figure 10. Funnel plot to evaluate publication bias in studies reporting on association
of exposure to PM2.5 with incidence of dementia and its subtypes
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Figure 11. Funnel plot to evaluate publication bias in studies reporting on association
of exposure to NOX with incidence of dementia and its subtypes

Figure 12. Funnel plot to evaluate publication bias in studies reporting on association
of exposure to NO2 with incidence of dementia and its subtypes
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Figure 13. Funnel plot to evaluate publication bias in studies reporting on association
of exposure to O3 with incidence of dementia and its subtypes

In addition, the risk of publication bias was evaluated by Egger’s regression test. The smallstudy effect was significant only for studies reporting on the association of exposure to
NOX with incidence of dementia. Publication bias estimates are limited by the small
number of studies that were eligible for meta-analysis, suggesting that the Egger’s test will
be underpowered to rule out potential publication bias (Table 11).
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Table 11. Egger’s Test for small-study effect
Studies
(n)

Bias Coefficient (95%CI)

t

P-value a

PM2.5

11

4.97 (-6.13, 16.07)

4.74

0.43

NOx
NO2

4
6

-14.77 (-27.1, -2.44)
-16.24 (-80.18, 47.69)

-3.50
-0.54

0.07
0.62

O3

4

17.03 (-32.21, 66.28)

1.01

0.42

Pollutant

a

Significance level is set at α > 0.10.

3.8

Sensitivity Analyses

The leave-one-out analysis was performed by excluding one study at the time and
evaluating the effect on the subgroup pooled estimate compared to the overall pooled
estimate.

3.8.1

Particulate Matter with Diameter < 2.5𝛍

The results of the sensitivity analysis for the association between exposure to PM2.5 and
the incidence of dementia is summarized in Table 12 (the model is presented in Fig 2).
In the leave-one-out analysis of the dementia subgroup, the pooled HR for the dementia
subgroup ranged from 1.01 to 1.15 and the Ι2 ranged from 67% to 96%. Additionally, the
pooled estimate for the overall association of exposure to PM2.5 ranged from 1.03 to 1.05
with and Ι2 ranging from 99% to 100%. The leave-one-out analysis for the studies that
reported on dementia as their outcome indicated that omitting the studies by Chen et al.
(75) or Smargiassi et al. (49) would make the association between exposure to PM2.5 and
dementia stronger by increasing the HR of dementia from 1.02 to 1.15, but would not
meaningfully affect the overall pooled estimate. Nonetheless, these two studies were the
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largest in this subgroup and the main observed HR in this subgroup can be attributed to
them. Removing studies with a small sample size (41, 43, 47) did not meaningfully affect
the subgroup and total estimations.
Sensitivity analysis did show a significant change in the overall association when the study
by either Jung et al. (39) or Yuchi et al. (48) was excluded from the model. On the other
hand, removing any study that reported on the incidence of the first-hospitalization with
dementia affected the subgroup estimate with pooled HR ranging from 1.02 to 1.10 and Ι2
ranging from 94% to 100%; however, excluding any of these studies made the association
in the subgroup statistically insignificant but did not meaningfully affect the overall
estimate of the association with pooled HR ranging from 1.01 to 1.05 and Ι2 ranging from
93% to 100%.
In addition, excluding studies from any continent did not affect the pooled HR estimate for
the association between exposure to PM2.5 and incidence of dementia with HR ranging
from 1.3 to 1.5 and Ι2 ranging from 94% to 100% (data are not shown).
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Table 12. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the
Association Between Exposure to PM2.5 and Incidence of Dementia a

Excluded Study
Dementia
All studies included
Carey et al. (2018) (42)
Chen et al. (2017) (46)
Grande et al. (2020) (43)
Ilango et al. (2020) (47)
Oudin et al. (2018) (41)
Smargiassi et al. (2020) (49)

Subgroup HR
(95%CI)

Subgroup
I2

Total HR
(95%CI)

Total I2

1.02 (1.01, 1.03)
1.01 (1.00, 1.03)
1.15 (1.06, 1.24)
1.01 (1.00, 1.01)
1.02 (1.00, 1.03)
1.02 (1.01, 1.03)
1.15 (1.06, 1.24)

95%
95%
96%
67%
96%
94%
96%

1.04 (1.02, 1.06)
1.04 (1.02, 1.06)
1.05 (1.03, 1.07)
1.03 (1.01, 1.05)
1.04 (1.02, 1.07)
1.04 (1.02, 1.06)
1.05 (1.03, 1.07)

100%
100%
99%
100%
100%
100%
100%

-

-

1.05 (1.03, 1.07)

100%

-

-

1.05 (1.02, 1.07)

100%

1.06 (1.01, 1.10)
1.10 (1.00, 1.20)
1.02 (0.97, 1.07)
1.07 (0.93, 1.23)

99%
94%
100%
97%

1.04 (1.02, 1.06)
1.05 (1.03, 1.07)
1.03 (1.01, 1.06)
1.01 (1.01, 1.02)

100%
100%
100%
93%

AD
Jung et al. (2015) (39)

NAD
Yuchi et al. (2020) (48)

First-time Hospitalisation
All studies included
Cerza et al. (2019) (51)
Kioumourtzoglou et al. (2016) (50)
Lee et al. (2019) (52)
a

Abbreviations: HR, hazard ratio, AD, Alzheimer’s disease; and NAD, non-Alzheimer dementia.

3.8.2

Nitrogen Oxides

The results of the sensitivity analysis for the association between exposure to NOX and the
incidence of dementia is summarized in Table 13 (the model is presented in Fig. 6).
Excluding neither of the studies could make the overall association of NOX and dementia
statistically significant, although the pooled HR estimate ranged from 1.01 to 1.09 and Ι2
ranged from 5% to 68%. When the study by Oudin et al. (65) was excluded, there was a
statistically significant association between exposure to NOX and incidence of dementia in
this subgroup (HR, 1.18; 95%CI, [1.04, 1.33]). In addition, the subgroup and the total
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heterogeneities were reduced (subgroup’s Ι2, 8%; and total Ι2, 5%) when the study by
Grande et al. (43) was excluded from the analysis.
Table 13. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the
Association Between Exposure to NOX and Incidence of Dementia a

Excluded Study
Dementia
All studies included
Andersson et al. (2018) (66)
Grande et al. (2020) (43)
Oudin et al. (2019) (65)

Subgroup HR
(95%CI)

Subgroup I2

Total HR
(95%CI)

TotalI2

1.09 (0.89, 1.70)
1.08 (0.96, 1.22)
1.04 (0.96, 1.14)
1.18 (1.04, 1.33)

46%
65%
8%
0%

1.04 (0.98, 1.10)
1.03 (0.98, 1.09)
1.01 (0.99, 1.02)
1.09 (0.95, 1.24)

57%
63%
5%
68%

-

-

1.09 (0.98, 1.21)

46%

First-time Hospitalization
Cerza et al. (2019) (51)
a

Abbreviations: HR, hazard ratio.

3.8.3

Nitrogen Dioxide

The results of the sensitivity analysis for the association between exposure to NO2 and the
incidence of dementia is summarized in Table 14 (the model is presented in Fig 7). Oneby-one exclusion of the studies in the dementia subgroup did not change the total pooled
HR (total HR range, 1.03 to 1.05; total Ι2 range, 78% to 96%); however, the pooled HR of
the dementia subgroup remained significant only when the study by Smargiassi et al. (49)
was excluded. In addition, only excluding the study by Cerza et al. (51) on the incidence
of the first-time hospitalization with dementia increased the overall pooled HR and made
the association statistically significant.
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Table 14. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the
Association Between Exposure to NO2 and Incidence of Dementia a

Excluded Study
Dementia
All studies included
Carey et al. (2018) (42)
Chen et al. (2017) (46)
Ilango et al. (2020) (47)
Smargiassi et al. (2020) (49)

Subgroup HR
(95%CI)

Subgroup I2

Total HR
(95%CI)

Total I2

1.07 (1.02, 1.12)
1.06 (1.00, 1.12)
1.08 (0.99, 1.19)
1.05 (1.00, 1.11)
1.9 (1.04, 1.14)

96%
97%
85%
98%
49%

1.04 (1.00, 1.08)
1.03 (0.99, 1.07)
1.03 (0.99, 1.07)
1.03 (0.99, 1.07)
1.05 (0.99, 1.12)

96%
96%
78%
96%
89%

-

-

1.04 (1.00, 1.09)

96%

-

-

1.06 (1.01, 1.10)

95%

NAD
Yuchi et al. (2020) (48)

First-time Hospitalization
Cerza et al. (2019) (51)
a

Abbreviations: HR, hazard ratio; and NAD, non-Alzheimer dementia.

3.8.4

Ozone

Results of the sensitivity analysis for the association between exposure to O3 and the
incidence of dementia is summarized in Table 15 (the model is presented in Fig 8). Leaveone-out analysis of studies did not make the association between exposure to O3 and the
incidence of dementia statistically significant. The pooled HR ranged from 0.85 to 1.04,
and Ι2 ranged from 69% to 86%.
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Table 15. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the
Association Between Exposure to O3 and Incidence of Dementia a
Total HR (95%CI)

Total I2

1.01 (0.91,1.11)

82%

Carey et al. (2018) (42)

1.03 (0.94, 1.13)

83%

Chen et al. (2017) (46)

1.04 (0.93, 1.17)

69%

0.85 (0.78, 1.10)

86%

0.96 (0.81, 1.15)

82%

Excluded Study
All studies included
Dementia

AD
Jung et al. (2015) (39)

First-time Hospitalisation
Cerza et al. (2019) (51)
a

Abbreviations: HR, hazard ratio; and AD, Alzheimer’s disease.

3.9

Other Analyses

Association between levels of pollutants was reported by some studies (Table 16). Since
the confidence intervals were not provided, it was not possible to perform meta-analysis
on the reported Pearson’s correlation coefficients. Reported estimates were heterogenous
and association could not be implied from the reported values. Nonetheless, a positive
association between PM2.5 and NO2 was reported by most of the studies while the
association between PM2.5 and O3 ranged from -0.96 to 0.51 and the association between
NO2 and O3 ranged from -0.99 to 0.66.
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Table 16. Pearson’s Correlation Coefficient Between Studied Pollutants a
PM2.5 &

PM2.5 &

NO2 &

NOx &

NOx &

NOx &

NO2

O3

O3

PM2.5

NO2

O3

Chen et al. (2017) (46)

0.38 b

0.38 b

-0.22 b

-

-

-

Carey et al. (2018) (42)

0.98

-0.96

-0.99

-

-

-

Cerza et al. (2019) (51)

0.66

-0.03

0.66

0.61

0.71

-0.12

Jung et al. (2015) (39)

-

-

0.07b

-

-

-

Lee et al. (2019) (52)

-0.25

0.51

-0.59

Smargiassi et al. (2020) (49)

0.75

-

-

-

-

Author, year

Yuchi et al. (2020) (48)

AD

0.24

-

-

-

-

-

NAD

0.52

-

-

-

-

-

a

Abbreviations: AD, Alzheimer’s disease; and NAD, non-Alzheimer’s disease.

b

correlation coefficients for the baseline levels.

While we intended to explore trends in the association between pollutants and dementia
overtime, it was not possible to do so since it was not possible to separate those who were
exposed before and after 2000 due to overlapping periods in the studies and the lack of
patient-level data. In addition, meta-analysis based on sex was not feasible since sex was
adjusted for in the original studies’ regression models.
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Chapter 4

4

Discussion

Existing evidence from cohort studies suggests that PM2.5 is significantly associated with
dementia. While other pollutants were not significantly associated with dementia, a
clinically-relevant association could not be ruled out given the width of the confidence
intervals. Meta-analysis showed that a 1μg/m3 increase in the level of PM2.5 is associated
with a 4% increase in risk of any type of dementia, with varied duration of follow-up across
the studies. In addition, the increased risk was higher for VaD (15%) in comparison to AD
(4%). Although the pooled estimate showed a 4% increase in risk of any type of dementia
per 10μg/m3 increase in NOX levels, the association was not statistically significant. There
was a 7% increase in risk of dementia per 10μg/m3 increase in NO2 when only studies that
reported incidence of dementia as the outcome were included; however, a 4% increase in
risk of any type of dementia was not statistically significant when NAD and the incidence
of the first-time hospitalization with dementia were included in the analysis. Finally, there
was no association between the incidence of dementia and O3. The sensitivity analysis
indicated that the pooled estimates were robust to exclusion of studies with small sample
size. Nonetheless, there was a high heterogeneity of effects across all the studies and all
the conducted analyses and leave-one-out analyses did not reduce the heterogeneity. The
small number of studies made it difficult to assess for potential publication bias; however,
visual inspection of funnel plots indicated that negative studies might have been missed
while the tests for ruling out publication bias were underpowered due to a few available
studies. Although studies that directly compared the highest to the lowest levels of
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exposure could not be included in the meta-analyses, all of them individually reported a
significant association between air pollution and dementia.
While not the focus of this meta-analysis, additional studies indicated that there was no
association between noise and dementia. Studies on the association of incidence of
dementia and road proximity were contradictory, and in one study the association was not
statistically significant when the model was adjusted for air pollutants (42). The presence
of APOE ϵ4 strengthened the association between exposure to PM2.5 and incidence of
dementia (40), but such an association was not seen with exposure to NOX (65).
The strength of this study was in the inclusion of the most important air pollutants
according to best available knowledge from existing studies. In the first search, we looked
for the most important air pollutants to design our study. Then we searched more
specifically for the more frequently investigated air pollutants. In addition, due to the small
number of studies and recency of the issue, there were only two meta-analyses on the
association of PM2.5 and incidence of dementia with few included studies, technical
problems and no meta-analysis on the association of NOX, NO2, or O3 with the incidence
of dementia. By including the latest studies published in 2020, this study is the first
systematic review and meta-analysis to include all air pollutants. Moreover, in order to
have a precise estimate, study authors were contacted, and new estimates based on the
original data were used to calculate pooled estimates.
This study has some limitations. Although air pollution has been associated with numerous
health problems (14-17), the association of air pollutants with dementia has only recently
attracted the attention of researchers, and therefore, there are few studies on this topic. In
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addition, the effect of air pollution on neuronal cells might be evident only after long-term
exposure, and given the nascent studies in the field, this makes drawing conclusions about
causal associations difficult. Dementia is a condition of the elderly and numerous risk
factors contribute to its pathology. Consequently, the incidence of dementia cannot be
attributed to one cause, and our reported association should be treated conservatively.
There was high heterogeneity across studies that maybe due to different study designs,
sample sizes, diagnosis methods, measurement of air pollutants, and different geographical
areas. Although the studies were population-based cohort studies, the recorded data and
diagnostic criteria were not the same. Some studies included almost everyone in the
registry and some studies used a proportion of the databases. Such studies are expensive,
which limits the design and analysis to the available budgets. In addition to the extremely
high price of accessing these databases, the access period to the data is limited. Once the
authors had the data and finished working with it, it was difficult for them to provide more
information, especially when the studies were conducted years ago. For this reason, a
number of authors could not provide additional information when we contacted them.
The levels of air pollutants were measured through different sources and various methods
were used to assign the pollutants’ levels to residential addresses and estimate the exposure
level in each individual. Most of the studies reported the mean annual level, which might
not be an accurate measure of air pollutants where some days of the year might have had
higher level of pollutants, for instance, school seasons. Moreover, climate may have
changed over the different periods of observation contributing to the variability among
studies. Another potential problem arises from land-use regression models. These models
may misclassify exposure because the exposure is not evaluated at the individual level, and
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depending on the number and distribution of the pollution measurement stations and
available information about potential confounders, the classification may be biased.
Furthermore, such a model does not consider daily or seasonal movements of individuals
and that they might be exposed to different levels of exposure during the day due to
working in a different place than their residential area. Furthermore, indoor pollution due
to using wood or fossil fuel for cooking or heating is not considered in these models. People
living in rural areas and on farms might be exposed to other types of pollutants that might
have a detrimental effect on cognitive function and be associated with dementia.
Furthermore, according to previous studies, the effect of pollution on cognitive function
may begin during childhood (33, 34) and continues through adulthood (35-38). Therefore,
where the population lived before enrolment in the study may be an important factor that
was not considered in most of the studies. This could be especially relevant for countries
with large populations of immigrants.
At the analysis level, the exposure variables were not treated the same across studies. Some
studies had dichotomized the exposure level, and some had divided the exposure level into
tertiles or quartiles. In this case, it was not possible to provide pooled estimates, as they
were not comparable. Even when the HR was provided for a certain unit increase in
pollutant’s level, they were not easily compared because they used various increments such
as IQR changes that varied depending on the total exposure levels in the studies. Although
the units were converted to a specific unit increase, this conversion may introduce
imprecision. In addition, upscaling the measurement units, for instance, conversion of oneunit change to 10-unit change, might provide estimates that are beyond what the original
data was intended to extrapolate. This was more evident when units of measurement were
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converted from ppb to μg/m3 or vice versa. In addition, NOX is a mixture of NO2 and
nitrogen monoxide and to convert the measurement units, the exact concentration of each
molecule in the examined sample should be known. Therefore, the converted estimate
might not be precise.
In addition, the difference in adjustment for variables in the regression models posed
challenges for our analysis. Although the studies had adjusted for risk factors of dementia,
they did not adjust for the same variables, and this may impact on their reported estimates.
Moreover, for most of the studies, the time between exposure and incidence of dementia
was not clear. Even in studies that reported the mean exposure period before diagnosis of
dementia, it was unclear when the pathology started and how long after the initiation of the
molecular pathology dementia was diagnosed. While some evidence points to a strong
association between CVD and dementia (79-81), and some evidence supports air pollution
as a known risk factor for CVD morbidity and mortality (14), only one of the included
studies evaluated the mediation role of CVD by providing three-year intervals for
developing CVD before diagnosis of dementia (47). Although most of the studies had
adjusted for CVD, they did not provide any information on the temporal association of air
pollution with CVD incidence and dementia.
The outcome definitions differed across the included studies. Some reported on the
incidence of dementia and some focused on subtypes of dementia, i.e., AD, VaD, and
NAD. In addition, three studies reported on the incidence of first-time hospitalization with
dementia (50-52), where the non-hospitalized individuals with dementia were not included.
Therefore, these studies were introduced to the analyses as subgroups and the analyses
focused on the total incidence of dementia irrespective of the reported subtypes because
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the clinical diagnosis of these subtypes does not necessarily confirm the involved
neuropathology (5). Moreover, using registry data has its limitations as the codes and
information are not complete which makes the certainty of the absence of dementia at
baseline and the precise diagnosis of the outcome less reliable, which might lead to
selection bias and misclassification of the outcome in included studies
Most of the studies were performed in North America and Europe, where air quality
regulation may be improved compared to other parts of the world. Low- and middleincome countries in Africa, Asia, as well as South and Central America may face altered
risks due to differing regulations, shorter life expectancy, and proximity of living
conditions to roads and other areas where pollutants are generated. In addition, indoor
pollution from cooking and heating and/or lighting are important additional contributors to
exposure to pollutants in low-income countries (82-90). Interestingly, one included study
in this meta-analysis indicated an association between PM2.5 from residential wood burning
and incidence of dementia in Umea, Sweden. Although their results indicated a 55%
increase in HR of dementia per 1μg/m3 increase in PM2.5 levels, the association was not
statistically significant (41). Studies should be conducted in these areas to investigate the
association of air pollution with dementia. In addition, future studies should implement the
lessons from previous studies to design cohorts that not only include and adjust for
important risk factors for dementia, but also consider the long-term effects of air pollution
on health and the period between effect on the central nervous system and diagnosis of
dementia. Given the interaction between and multitudes of exposure to each of these
pollutants in combination, the association of air pollution with the incidence of dementia
cannot be definitively attributed to increased levels of any one specific pollutant alone.
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In addition, PM2.5 is defined based on the diameter of the particle and it can deliver
numerous toxic ingredients as well as viruses and bacteria into the human body (22, 91).
Therefore, it is difficult to assign the observed association to a particle that might have
various ingredients potentially differing from region to region. Additional studies may
provide better insight on the role PM2.5 plays on human health.
Notwithstanding the limitations, our study has some implications for public health and
government authorities, researchers, and the public.
The world population is increasing, and advances in medical care and social wellbeing
have improved life expectancy. This means that the elderly will constitute a large
proportion of the population and therefore, conditions associated with ageing, such as
dementia, will be more frequent. It is estimated that dementia cases will triple by 2050
(11), and this may translateinto a ‘tsunami of dementia’ in the near future. Detecting and
understanding preventable risk factors may help to mitigate this growth. One of the
plausible and preventable contributors to dementia is air pollution. According to the
“Ambient (outdoor) air quality and health” report by WHO in 2016, more than 90% of the
world population is living in regions with higher than recommended levels of air pollution
(21). Thus, if there is a causal association between air pollution and dementia, a large
proportion of the population are at increased risk of developing dementia in the future. The
sheer magnitude underscores the importance of further research to understand this
association and effective mitigation efforts.
While more studies are needed to evaluate the causal pathway between air pollution and
dementia, current evidence points to a plausible association that is worthy of attention.
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Since most of the pollution in the included studies concerned traffic-related air pollution,
governments should improve regulations for air quality assessment and accelerate the
transition from fossil fuels to sustainable energies such as electricity. In addition, public
health authorities should consider programs to prevent dementia by reducing exposure to
preventable risk factors for dementia including air pollutants. Such a plan mandates an
interdisciplinary approach involving governmental, health, community, and funding
sectors.
These findings are also important to regular citizens. By understanding the imposed risk of
dementia through exposure to air pollution, individuals would consider using sustainable
energies, living away from regions with a high level of pollutants, and advocate for global
interventions to reduce air pollution.
The current study draws a scratch of a big picture that most of it are not completely
understood yet. Further research is needed to improve our knowledge and understanding
of the association between air pollution and dementia. Future prospective population-based
studies should consider the limitations of previous studies such as measuring exposure
more precisely with adequate follow-up over time to evaluate the effect of moving from
one region to another. In addition, in countries with significant migration or immigration,
the exposure before immigration should be considered. Dementia should be defined using
standardized definitions, preferably with clinical assessment rather than by registry codes
to prevent misclassification of the outcome. Moreover, prognostically relevant factors
should be included in the analysis and if possible, the mediation role of other conditions
such as CVD should be evaluated. In addition, the duration of exposure prior to developing
dementia should be evaluated. Finally, sex should be included as a subgroup not just a
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variable in the regression models so that difference between males and females can be
evaluated. In conclusion, this meta-analysis of cohort studies indicates a significant
association between exposure to PM2.5 and incidence of dementia. However, there were
few studies on other pollutants, and the high heterogeneity of effects across studies should
be considered in interpreting the results.
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Appendices

PubMed

Appendix A: Search Terms
Alzheimer

Pollution

("Alzheimer
Disease"[Mesh]
OR
"Dementia"[Mesh]
OR
alzheimer* OR dementia)

("air pollution"[MeSH Terms] "Particulate Matter"[ MeSH Terms] OR "Nitrogen Oxides"[ MeSH
Terms] OR "Nitrogen Dioxide"[ MeSH Terms] OR "Nitrous Oxide"[ MeSH Terms] OR "Ozone"[ MeSH
Terms] "Petroleum"[ MeSH Terms] OR "Sulfur Oxides"[ MeSH Terms] OR (air pollut*) OR
(Particulate Matter*) OR (Nitrogen AND (Oxide* OR dioxide*)) OR (Nitrous AND Oxide*) OR
(Ozone) OR (Sulfur AND Oxide*) OR smok* OR "Cooking"[Mesh] OR cooking* OR "environmental
pollution"[MeSH Terms] OR "Environmental Pollutants"[Mesh Terms] OR "Environmental
Exposure"[Mesh] OR "traffic-related pollution"[MeSH Terms] OR "Vehicle Emissions"[Mesh Terms]
OR traffic-related OR traffic* OR car* OR Vehicle* OR road* OR transport* OR road-proximity OR
"Fossil Fuels"[Mesh] OR "Petroleum Pollution"[Mesh] OR gas OR gasoline* OR diesel* OR fossil*
OR petroleum* OR fuel* OR environment* OR "PM2.5" or PM10 or NOx OR NO2) AND (pollut* OR
exposur* OR emission*)
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Web of Science

Scopus

Alzheimer

Pollution

(TITLE-ABS-KEY
(TITLE-ABS-KEY ( particulate AND matter* ) OR TITLE-ABS-KEY ( nitrogen AND oxide* ) OR TITLE(alzheimer*) OR TITLE- ABS-KEY ( nitrogen AND dioxide* ) OR TITLE-ABS-KEY ( nitrous AND oxide* ) OR TITLE-ABS-KEY (
ABS-KEY (dementia))
ozone ) OR TITLE-ABS-KEY ( NO2 ) OR TITLE-ABS-KEY ( NOx ) OR TITLE-ABS-KEY (PM2.5) OR TITLEABS-KEY ( smok* ) OR TITLE-ABS-KEY ( cooking ) OR TITLE-ABS-KEY (PM10) OR TITLE-ABS-KEY (
environment* ) OR TITLE-ABS-KEY ( traffic* ) OR TITLE-ABS-KEY ( car* ) OR TITLE-ABS-KEY ( vehicle*
) OR TITLE-ABS-KEY ( transport* ) OR TITLE-ABS-KEY ( road AND proximity ) OR TITLE-ABS-KEY ( road
) TITLE-ABS-KEY ( fuel* ) OR TITLE-ABS-KEY ( fossil* ) OR TITLE-ABS-KEY ( petroleum* ) OR TITLEABS-KEY ( gas ) OR TITLE-ABS-KEY ( gasoline* ) OR TITLE-ABS-KEY ( diesel )) AND ( TITLE-ABS-KEY (
pollut* ) OR TITLE-ABS-KEY ( expos* ) )
TS= (alzheimer*
dementia)

OR TS=(particulate AND matter*) OR TS=(nitrogen AND oxide*) OR TS=(nitrogen AND dioxide*) OR T
S=(NOx OR NO2 OR PM2.5 OR PM10 OR ozone OR O3 OR smoke* OR cooking OR environment*
OR traffic* OR car* OR vehicle* OR transport OR road* ) OR TS=(road AND proximity) OR TS=(foss
il* OR fuel* OR petroleum* OR gasoline* OR diesel*) AND TS = (Pollut*)

OVID MEDLINE, PSYCHINFO, and EMBASE
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Alzheimer

Pollution

1. exp dementia/ or exp
Alzheimer disease/ or
alzheimer*.mp.
2.
exp
semantic
dementia/
or
exp
frontotemporal
dementia/ or exp "mixed
depression
and
dementia"/ or exp Pick
presenile dementia/ or
exp
frontal
variant
frontotemporal
dementia/ or exp senile
dementia/
or
exp
multiinfarct dementia/
or exp dementia/ or exp
Cornell
Scale
for
Depression in Dementia/
or dementia.mp. or exp
presenile dementia/

3. exp particulate matter/ or exp air pollution/ or air pollut*.mp. or exp air pollutant/
4. exp nitrogen dioxide/ or exp nitrogen oxide/ or nitrogen oxide*.mp. or exp ozone/
5. nitrogen dioxide*.mp.
6. exp nitrous oxide/ or exp nitrous oxide emission/ or nitrous oxide*.mp.
7. ozone*.mp.
8. exp aerosol/ or exp airborne particle/ or particulate matter*.mp.
9. exp pollutant/ or exp pollution/ or pollut*.mp.
10. exp smoking/ or smok*.mp. or exp nicotine/
11. environment*.mp.
12. exp traffic/ or exp traffic related pollution/ or traffic-related pollut*.mp.
13. exp motor vehicle/ or exp exhaust gas/ or vehicle emission*.mp.
14. (road* or road proximity or vehicle* or car* or transport*).mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw,
fx, dq, nm, kf, ox, px, rx, ui, sy, tc, id, tm, mh]
15. exp petroleum derivative/ or petroleum*.mp. or exp petroleum/
16. exp fossil fuel/ or fossil fuel*.mp.
17. gasoline.mp. or exp gasoline/
18. exp diesel fuel/ or exp diesel engine/ or diesel*.mp.
19. exp fossil energy/ or fossil.mp.
20. 3 or 4 or 5 or 6 or 7 or 8 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
21. "PM10".mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh]
22. "PM2.5".mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh]
23. NO2.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh]
24. NOx.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh]
25. 20 or 21 or 22 or 23 or 24
26. 1 and 2 and 25
27. 9 and 26
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